genomic testing  rosetta gx™ by rosetta genomics® get in touch rosettagx™ testing services provide physicians a direct path for diagnosing cancer and optimizing patient treatment outcomes view clinical validation for rosettagx reveal  thyroid classifier read more view analytical validation for rosettagx reveal  thyroid classifier read more learn about our thyroid test  rosettagx reveal watch now view clinical validation for rosettagx reveal  thyroid classifier read more view analytical validation for rosettagx reveal  thyroid classifier read more learn about our thyroid test  rosettagx reveal watch now rosettagx provides physicians a direct path for diagnosing cancer and optimizing patient treatment outcomes your cancer roadmap is here specialized diagnostic prognosticand predictive testing genomic answers that revealthe optimal treatment plan learn more micrornabased assay for diagnosing tumor tissue origin oncologist   flexible ordering options order now view our specialty tests view for our investors press releases  presentations billing summary  rosetta genomics® get in touch directory of services order tests billing summary rosetta genomics believes every patient who needs our tests should be able to receive them we provide highquality medically necessary tests based on established medical guidelines the information in the following sections addresses commonly asked health plan and billing questions if you would like more information please contact rosetta member services  mondayfriday  am –  pm est what toexpect frequently askedquestions financialassistance plan medicareinformation what to expect rosetta genomics accepts thirdparty assignment and will submit a claim to your primary health plan you will receive an explanation of benefits eob from your health plan and a welcome letter from rosetta genomics that includes a statement of services rendered and submitted to your health plan appeals can take  days or more depending on the timely collection of the information needed to file an appropriate appeal rosetta will submit primary and secondary appeals before billing the final amount specified by your health plan as patient financial responsibility rosetta genomics will send the patient an invoice for any copays deductibles or coinsurances as determined by your health plan payment is due upon receipt customer service associates are available to discuss the claims appeals and billing process and the options available to you to reduce your outofpocket expenses and optimize your eligible benefits all rosetta genomics patients are eligible to apply for our financial assistance program glossary of health plan terms found on most eobs an eob is a document provided by your health plan that explains how your claim was processed and paid most health plans use a unique format for their eobs so it is important to know and understand your companys format if you have questions please contact your health plan directly term description account number a number assigned to each bill by rosetta genomics amount paid the portion of the total bill that has been paid by your health plan allowed charges the amount the health plan approved for processing claim number the number assigned by your health plan to the rosetta genomics claim coinsurance the portion of the allowed charges usually a certain percentage that is the patient’s financial responsibility this amount can differ based on innetwork or outofnetwork determinations contract adjustment the portion of the total bill that is not owed to rosetta genomics by either the health plan or the patient due to a contractual agreement between the health plan and rosetta genomics coordination of benefits the amount owed by another health plan when the patient has secondary coverage copay the amount required to be paid by the patient per visit or encounter date of service the date on which the laboratory testing was reported to your physician deductible a specific annual dollar limit that must be paid by the patient before the patient’s insurance will begin reimbursing for covered services excess charges any portion of the total charges that that the health plan determines is greater than the allowed charges this amount may be based on the contractual agreement between the health plan and rosetta genomics or may be an amount limiting the ucr charge amount usual customary and reasonable explanation of payment the section of an eob that uses reason and denial codes to explain the payments made ipa independent practice association a group of allied physicians andor health professionals who coordinate care usually under a capitated or prepaid arrangement noncovered a service that is excluded from your benefit plan which is considered nonpayable by your health plan the patient may be responsible for this amount patient information information including patient name patient id number responsible party subscriber insured’s name and employee’s group number patient responsibility the amount your health plan has determined the patient owes rosetta genomics this includes copay coinsurance deductibles and any percentage of balance if payment is less than  of the billed amount provider information rosetta genomics name provider id and mailing address service code a cpt code or other hcpcs code representing the service provided submitted charges the amount billed by rosetta genomics units the number of items included in the service ucr the usual customary and reasonable fee for services often referred to as the list price how do i make a payment how do i make a payment if you receive a rosetta genomics statement there are several options for payment check or money order please make it payable to rosetta genomics and mail it to the address below credit or debit card you may complete the form on your invoice or to pay by phone please call us at the number below a receipt can be mailed to you upon request please mail your payment to the address on your statement we also accept paypal payments please contact rosetta genomics customer service to make payment did you bill my primary health plan for these charges rosetta genomics accepts thirdparty assignment for all health plans and will bill your health plan directly we require full and accurate health plan information from you and your provider if the health plan information we receive is incorrect or missing information we may not be able to file a claim with your health plan my bill shows a claim was filed with my health plan why am i receiving a bill for the full amount you may receive a bill for the full amount if  your health plan information is incorrect or outdated in our system  your health plan didnt reply to our claim in a timely manner  your health plan denied payment for some or all of our services contact your health plan at the customer service phone number on the back of your member card if they received our claim ask them why payment has been delayed if they did not receive the claim make sure we have your updated health plan information why do i have a balance left over after my insurance has paid  you have nongovernment insurance and are responsible for a copayment coinsurance deductible andor noncovered services  you have medicare and are responsible for  of the amount medicare has set as the cost of the test  you have medicare and have signed an abn advanced beneficiary notice in this case you may owe the difference between what medicare paid and what they have set as the cost of the test most health plans today have deductibles coinsurance or required copayment amounts you must pay if you believe this portion of your bill is your health plans responsibility contact them using the customer service phone number on the back of your insurance card do you offer payment plans in some cases yes contact rosetta genomics customer service to determine your eligibility my name address or other personal information changed who should i notify please contact customer service and we will be happy to update your information and submit a corrected claim when appropriate why have i received an invoice from rosetta genomics you may not be aware your physician has sent your specimen to rosetta genomics for testing some of the high complexity tests we provide are only available through rosetta genomics the statement you receive is for medically necessary testing ordered by your physician and provided by a rosetta genomics laboratory the statement is for laboratory testing fees only and is separate from any bill you may have received from your physician andor paid at your physicians office please refer to the message on your rosetta genomics statement or the explanation of benefits eob from your health plan for more specific information about why you received a statement you may receive a bill for some or all of the billed amount because  your health plan information was not received or the wrong health plan information was received with your test request  your health plan processed the claim and denied payment see your eob for explanation  your health plan processed the claim and applied the balance to your health plan copay coinsurance or deductible requirement  the insurance carrier did not respond to the claim am i required to pay past due balances to obtain future services your payments are due upon receipt a payment for all past due balances is required at the time of service rosetta genomics reserves the right to refuse laboratory services for failure to pay for past services can rosetta genomics tell me how much i can expect to pay for my tests the price you pay for rosetta genomics testing depends on several variables  if you have valid health plan coverage for the services ordered by your physician  rosetta genomics is or is not a participating provider in your health plan network  your health plan or medicare does not pay for some or all of the tests ordered by your physician because they do not consider the tests medically necessary  your healthcare provider or physician has an agreement with rosetta genomics how can i have medicare send my invoice to my secondary health plancarrier medicare automatically forwards or “crosses over” your claim to your secondary health plan or insurance carrier when medicare or your medicare advantage health plan are aware you have secondary coverage sometimes referred to as medigap coverage you must inform medicare directly of your secondary insurance coverage how do i submit secondary health plan or insurance carrier information rosetta genomics will file eligible claims to a secondary health plan or insurance carrier when it is provided by the patient or responsible party to submit your secondary insurance information please call rosetta genomics customer service does rosetta genomics have a program for patients experiencing financial hardship andor patients who do not have insurance rosetta genomics offers payment plans in monthly installments until your balance is paid in full we also offer the rosetta genomics financial assistance plan which provides free or reducedfee laboratory services to those who qualify based on us department of health and human service poverty guidelines are rosetta genomics services eligible for flexible spending accounts “fsa” or health reimbursement account “hra” yes you will need to contact your fsa or hra administrator for instructions on filing requirements how can i find out if rosetta genomics is a participating provider with my health plan rosetta genomics is a participating provider with a growing list of health plans covering more than  million lives in the united states however it is the patients’ responsibility to verify benefits before services are performed any questions regarding coverage should be directed to your health plan i don’t understand why my testing wasn’t paid by my health plan please refer to the messages and reasondenial codes on your health plan eob and your rosetta genomics statement for more specific information about why you received a statement if you have additional questions or concerns please contact your health plan first why was my health plan billed with incorrect insurance information your health plan is billed using the information provided to us on the original test order from your physician also called a test requisition sometimes the information provided on the requisition is incorrect to ensure your health plan is billed properly please present your insurance card at each physicians office please also make sure your physicians office has your most current health plan and billing information including your current address contact information and correct date of birth why do i have to give my insurance information each time i visit my physician americans change their health plan coverage frequently on average every three years open enrollment occurs annually it is important to provide your most current health plan information at each visit to ensure you receive your eligible benefits i received information from my health plan about my benefits and i do not understand all of the information can you help me please contact your health plan directly information about how a specific claim is processed should be provided to you from your health plan with their explanation of benefits eob you can also review the glossary of health plan terms provided on this website which may help you interpret the information provided by your health plan can rosetta genomics tell me if my testing is covered by my health plan no rosetta genomics does not know each individual patient’s health plan coverage it is the patients responsibility to verify benefits before services are performed any questions regarding coverage should be directed to your health plan why does my rosetta genomics statement include charges for additional tests that were not on my physicians original order your physician may have requested additional testing after the order was submitted or your physician ordered a test that includes a reflex test reflex testing is performed when the results of your original test require more detailed information about the findings of the initial test where does rosetta genomics obtain the diagnosis information related to my claim rosetta genomics obtains diagnosis information from your ordering physician’s office if your health plan denied your claim due to the diagnosis code please contact your physicians office and ask them to call rosetta genomics customer service to update the diagnosis code i received a statement from rosetta genomics requesting additional information what should i do please send the requested information to the address or fax number listed on your statement you can also call the customer service phone number listed on your statement if the message on your statement indicates that your health plan needs more information from you in order to process your claim please contact your health plan directly what happens if i cannot afford to pay my bill rosetta genomics has a financial assistance plan for uninsured and under insured patients or those who may not be able to afford their associated outofpocket costs limits and conditions apply contact customer service for more information on these programs financial assistance plan rosetta genomics offers testing at reduced or no cost to uninsured or underinsured patients in the us who meet specific financial criteria only us patients are eligible due to regulatory limitations patients who are recipients of us government funded programs such as medicaid medicare and tricare are not eligible to apply financial assistance criteria a separate rosetta genomics financial assistance program application is required download here the financial criteria below are for informational purposes only financial assistance program applications submitted with specimens without prior approval from rosetta genomics will not be deemed to be qualified applications note the financial criteria above are based upon the  united states department of health  human services hhs poverty guidelines multiplied x  and are subject to change if the patient does not qualify for financial assistance rosetta genomics offers payment plans in which the patient can make monthly payments over   or  months rosetta genomics reserves the right to terminate or modify its financial assistance program at any time without notice patients’ choosing to selfpay or prepay for rosetta genomics testing are not eligible for the rosetta genomics financial assistance plan  for international orders the patient prepay option does not include shipping thirdparty billing information rosetta genomics is a participating provider with medicare and covers more than  million americans through various managed care agreements thirdparty payers request the information listed below be provided in order to process a claim patient’s complete name patient’s date of birth patient’s gender patient’s address patient’s telephone number patient’s status inpatient outpatient or nonpatient subscriber’s name if other than patient subscriber’s date of birth complete mailing address of patient or subscriber patient’s relationship to subscriber identified as self spouse child and other ordering physician’s last and first name treating physician’s last and first name specimen collection date and time list all applicable icdcm diagnosis codes to their highest level of specificity copy of card front  back private insurance complete name and full address of the insurance company medicare medicaid or insured’s id member number as it appears on the insurance card grouppolicy number as it appears on the insurance card employer’s name medicare billing medicare reimburses rosetta genomics differently depending on the test provided for tests reimbursed based on the medicare physician fee schedule medicare will reimburse at  of the fee schedule amount and the patient is billed for the remaining  coinsurance and any deductible amounts for tests reimbursed based on the medicare clinical laboratory fee schedule medicare typically reimburses rosetta genomics at  of the allowable amount completing a medicare billing request indicate with a mark the “medicare” billing option on the test request form complete patient demographics full name address telephone number date of birth and gender medicare number as it appears on the medicare card specimen collection date and time or date of surgery and time patient’s place of service status inpatient outpatient or nonpatient ordering physician’s first and last name and npi number treating physician’s first and last name and npi number all applicable icdcm diagnosis codes to their highest level of specificity secondary health plan or insurance carrier medigap information if applicable advance beneficiary notice abn if required medicaid billing rosetta genomics does not participate with any medicaid plans however rosetta genomics will provide testing services to medicaid enrollees who are willing to pay in advance or have applied and been certified with our financial assistance plan completing a medicaid billing request indicate with a mark the “medicaid” billing option on the test request form medicaid claim filing requirements vary by state and health plan but generally require patient’s complete name address telephone number and date of birth complete medicaid member number and the state as it appears on the medicaid card indicate primary or secondary information specimen collection date and time patient’s place of service status inpatient outpatient or nonpatient ordering physician’s first and last name ordering physician’s signature necessary only in states where required treatingpcppmpclinician’s first and last name providerauthorization number—where required list all applicable icdcm diagnosis codes to their highest level of specificity note if medicaid denies payment for noncovered services or eligibility reasons the patient may be responsible for the payment bladder tests  rosettagx™ by rosetta genomics® get in touch directory of services order tests bladder cancer origin nextgen thyroid lung prostate bladder breast kidney bladder cancer can present in various grades and stages fgfr has been shown to identify lowgrade lower risk bladder cancer from urine or tissuebased specimens while urovysion is an fda approved test that has been proven to be very accurate in identifying highgrade higher risk disease fgfr urine fgfr tissue urovysion fgfr urine the bladder portfolio of tests includes a proprietary biomarker called fgfr mutation analysis which can be tested together with cytology and urovysion from a single urine specimen bladder cancer can present in various grades and stages and studies have shown fgfr to be associated with lowgrade lower risk tumors and predict better overall survival  of  cystobiopsy negative patients were fgfr negative specificity  and  of  fgfr positive patients were cystobiopsy positive ppv  associated with lowgrade early stage bladder cancer and predicts better overall survival fgfr has been shown to detect tumors in the upper urothelial tract from voided urine specimens rapid turnaround time of  days can be combined with urovysion toassist in covering the completespectrum of bladder cancer references halling kc king w sokolova ia et al a comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma j urol  van rhijn b van der kwast t liu l et al the fgfr mutation is related to favorable pt bladder cancer j urol  liu x zhang w geng d et al clinical significance of fibroblast growth factor receptor mutations in bladder cancer a systematic review and metaanalysis genet mol res  karnes rj fernandez ca shuber ap a noninvasive multinalyte urinebased diagnostic assay for urothelial cancer of the bladder in the evaluation of hematuria mayo clin proc   van oers j zwarthoff e rehman i et al fgfr mutations indicate better survival in invasive upper urinary tract and bladder tumours eur urol  van rhijn bw vis an van der kwast th et al molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor  and mib is superior to pathologic grade for the prediction of clinical outcome j clin oncol  kamat am dickstein rj messetti f et al use of fluorescence in situ hybridization to predict response to bacillus calmetteguérin therapy for bladder cancer results of a prospective trial j urol  fgfr tissue molecular grading through the use of proprietary biomarker fgfr can help determine the prognostic profile of bladder cancer patients through the fgfr tissue test this test analyzes the mutation and ki levels in the tissue which together helps to determine whether a patient’s prognosis is favorable intermediate or poor assists with initial diagnosis and prognosis improves risk stratification of your nonmuscle invasive bladder cancer patients patients with fgfr mutations and low ki levels appear to have better overall survival rapid turnaround time of  days references halling kc king w sokolova ia et al a comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma j urol  van rhijn b van der kwast t liu l et al the fgfr mutation is related to favorable pt bladder cancer j urol  liu x zhang w geng d et al clinical significance of fibroblast growth factor receptor mutations in bladder cancer a systematic review and metaanalysis genet mol res  karnes rj fernandez ca shuber ap a noninvasive multinalyte urinebased diagnostic assay for urothelial cancer of the bladder in the evaluation of hematuria mayo clin proc   van oers j zwarthoff e rehman i et al fgfr mutations indicate better survival in invasive upper urinary tract and bladder tumours eur urol  van rhijn bw vis an van der kwast th et al molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor  and mib is superior to pathologic grade for the prediction of clinical outcome j clin oncol  kamat am dickstein rj messetti f et al use of fluorescence in situ hybridization to predict response to bacillus calmetteguérin therapy for bladder cancer results of a prospective trial j urol  urovysion urovysion is the first and only fdaapproved molecular urine test that detects chromosomal changes associated with bladder cancer this test has been shown to be highly sensitive for highgrade higher risk disease it also aids in the initial diagnosis of bladder cancer and detects bladder cancer recurrence up to  months sooner than current diagnostic methods can be combined with fgfr urine to assist in covering the complete spectrum low grade to high grade of bladder cancer available via our tcpc virtual platform overall specificity of  and a combined specificity with cystoscopy of  rapid turnaround time of  days in addition a positive urovysion result has been shown to predict recurrence during bcg therapy additional information for pathologists working in conjunction with pathology laboratories around the country rosettagx provides the technical component tc of urovysion while the pathologist provides the professional component pc it is not necessary for pathology laboratories to acquire specialized equipment or modify facilities additional information for urologists urovysion is intended for initial diagnosis of patients with hematuria or for monitoring recurrent urothelial carcinoma consider these hypothetical circumstances that a urologist may consider urovysion a urologist who commonly uses cystoscopy with cytology and sees a high rate of recurrence in bladder cancer patients may choose to order urovysion as an aid in detecting bladder cancer early a urologist who commonly uses cystoscopy without cytology and seeks to detect carcinoma in situ cis early may order urovysion as an additional diagnostic aid a urologist who uses cystoscopy with other tumor markers and who has found that these markers can be affected by bcg or inflammation may add urovysion to the standard diagnostic procedures read studies about urovysion halling k king w sokolova i et al a comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma j urol  sarosdy m schellhammer p bokinsky g et al clinical evaluation of a multitarget fluorescent in situ hybridization assay for detection of bladder cancer j urol   sarosdy m kahn p ziffer m et al use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria j urol  kamat a dickstein r messetti f et al use of fuorescence in situ hybridization to predict response to bacillus calmetteguérin therapy for bladder cancer results of a prospective trial j urol  references halling kc king w sokolova ia et al a comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma j urol  van rhijn b van der kwast t liu l et al the fgfr mutation is related to favorable pt bladder cancer j urol  liu x zhang w geng d et al clinical significance of fibroblast growth factor receptor mutations in bladder cancer a systematic review and metaanalysis genet mol res  karnes rj fernandez ca shuber ap a noninvasive multinalyte urinebased diagnostic assay for urothelial cancer of the bladder in the evaluation of hematuria mayo clin proc   van oers j zwarthoff e rehman i et al fgfr mutations indicate better survival in invasive upper urinary tract and bladder tumours eur urol  van rhijn bw vis an van der kwast th et al molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor  and mib is superior to pathologic grade for the prediction of clinical outcome j clin oncol  kamat am dickstein rj messetti f et al use of fluorescence in situ hybridization to predict response to bacillus calmetteguérin therapy for bladder cancer results of a prospective trial j urol  rosetta genomics  wikipedia rosetta genomics from wikipedia the free encyclopedia jump to navigation search rosetta genomics type public nasdaq rosg industry biotechnology founded  founder dr isaac bentwich headquarters rehovot israel and jersey city us key people ken berlin president and ceo dr isaac bentwich founder products micrornabased diagnostic tests and therapeutics number of employees  as of  website wwwrosettagenomicscom rosetta genomics ltd is a molecular diagnostics company with offices in israel and the united states that uses microribonucleic acid microrna biomarkers to develop diagnostic tests designed to differentiate between various types of cancer the company expects the first three tests based on its technology to be submitted for regulatory approval in  the diagnostic tests will differentiate between squamous and nonsquamous nonsmall cell lung cancer nsclc differentiate between adenocarcinoma and peritoneal mesothelioma and seek to identify the origin of tumors in patients representing cancer of unknown primary cup using a single microrna the highly sensitive highly specific test for squamous and nonsquamous lung cancer has passed the prevalidation phase  and has been submitted for approval to the new york state department of health clinical laboratory evaluation program in april  in april  nature biotechnology published a study by rosetta genomics’ scientists whose findings demonstrate micrornas significant potential to act as effective biomarkers that may be applied in a diagnostic test designed to identify the primary tumor site in patients cup in addition to its diagnostic programs rosetta genomics is collaborating with isis pharmaceuticals to develop a micrornabased therapy for hepatocellular carcinoma hcc a form of liver cancer contents  intellectual property  platform technologies  licenses and collaborations  history  references  external links intellectual propertyedit rosetta genomics has developed a microrna discovery process combining powerful informatics with highthroughput biological techniques this has led to the discovery of a large portion of today’s known human and viral micrornas in  the us patent and trademark office issued rosetta genomics with two patents relating to micrornas in march  rosetta genomics announced that the us patent and trademark office has issued allowance for two of the companys patent applications on human and viral micrornas platform technologiesedit rosetta genomics has developed several proprietary technologies that enable the company to work with micrornas at the basis of these technologies are proprietary microrna extraction protocols that include sensitive extraction of micrornas from most body fluids including serum urine saliva with virtually no microrna lost in the extraction process the company has also developed a microrna extraction protocol from formalin fixed paraffin embedded or ffpe samples this allows extraction of micrornas from samples preserved at room temperature once micrornas are extracted rosetta genomics’ technology is capable of detecting and quantifying the micrornas using two custom designed platform technologies which utilize quantitative real time pcr or qrtpcr and microarrays the company’s proprietary microarray platform covers approximately  human micrornas including approximately  micrornas  which are rosetta genomics’ proprietary micrornas the array’s high specificity allows discriminating homologous family members licenses and collaborationsedit in january  rosetta genomics announced a collaboration agreement with the henry ford health system in detroit michigan to develop micrornabased diagnostics and prognostics for brain cancer also in january  rosetta genomics announced that its subsidiary rosetta genomics inc has received a license to use roche molecular systems pcr technology in micrornabased diagnostic tests in september  rosetta genomics said it will work with new york university medical center to develop a micrornabased diagnostic test for melanoma in may  rosetta genomics announced columbia university medical center would utilize its clinical laboratory improvement amendments cliacertified laboratory to perform the clinical validation of rosetta genomics’ diagnostics program for cancer of unknown primary in february  isis pharmaceuticals inc and rosetta genomics said they will collaborate to develop antisense drugs that inhibit microrna in the liver to treat cancers there antisense drugs are a class of compounds that interfere with genetic material that gets translated into harmful proteins historyedit rosetta genomics was founded by isaac bentwich in  to pursue commercial applications of microrna research the company had its ipo on march   and is traded on the nasdaq rosetta genomics expects the funds raised to advance its micrornabased diagnostic and therapeutic cancer products through initial clinical validation defined as success in identifying the specific biomarker panels via blinded tests of samples supplied by medical institutions referencesedit  chambers heather isis alnylam pair to seek diseasefighting drugs san diego business journal september    a b columbia university medical center and rosetta genomics announce columbia universitys submission of the first cancer diagnostic test based on rosetta genomics proprietary microrna technology for approval to the new york state department of health clinical laboratory evaluation program forbescom april    a b rosetta genomics ltd completes prevalidation phase for first diagnostic production reuters october    a b boggs jennifer rosetta genomics ipo raising m for microrna workbioworld today february    rosenfeld n aharonov r meiri e et al april  micrornas accurately identify cancer tissue origin pdf nat biotechnol   – pmid  doinbt   antisense oligonucleotide heptacellular carcinoma isisrosetta genomics isis rosetta genomics licensing agreement rd focus drug news march    bentwich i avniel a karov y et al july  identification of hundreds of conserved and nonconserved human micrornas pdf nat genet   – pmid  doing   httpmoneycnncomnewsnewsfeedsarticlesprnewswireprnewsusprukmhtm rosetta genomics announces expansion of its microrna intellectual property estate cnnmoneycom april    httpnewsmoneycentralmsncomproviderproviderarticleaspxfeedbcomdate idcideiptnmrzngoaklymcq market reportin play wires msnmoneycom march   httpwwwusptogovwebpatentspatogweekoghtmlushtml uspto web site uspto patent fulltext and image database  other news to note bioworld today april    henry ford hospital and rosetta genomics to develop micrornabased diagnostics for brain cancer company reports january    nanogen inc licenses mgb probe technology to rosetta genomics ltd reuters significant developments december    rosetta and rockefeller enter microrna agreement datamonitor news and comment june    business diary acquisitions crains detroit business february    httpwwwfdanewscomnewsletterarticlearticleidissueid rosetta genomics licenses roche pcr technology fdanews device daily bulletin january    everitt jay rosetta genomics ltdrosg to work in collaboration with nyu medical center knobias september    rosetta genomics ltd signs agreement with columbia university medical center reuters may    isis rosetta join on cancer treatment associated press february    httpwwwforbescombusinessforbeshtml herper matthew and robert langreth treasures in the trash forbes december    httpwwwhooverscomrosettagenomicsidfreecoprofilexhtml hoovers web site rosetta genomics company description  alnylam pharma shares rise on cantor fitgeralds microrna technology outlook associated press september   external linksedit company website v t e israeli companies traded on nasdaq healthcare alcobra biolinerx biondvax pharmaceutical compugen enzymotec given imaging kamada mazor robotics medigus oramed pharmaceuticals perrigo company pluristem therapeutics rewalk robotics rosetta genomics syneron medical communication  networks allot communications alvarion audiocodes b communications ceragon networks dsp group ezchip semiconductor gilat satellite networks internet gold golden lines orckit communications partner communications company radcom radvision rit technologies rr media software attunity bluephoenix solutions bos better online solutions check point software technologies clicksoftware technologies commtouch software cimatron cyberark formula systems  jacada magic software enterprises mind cti nice systems perion network radware sapiens international corporation nv verint systems wix electronics camtek ceva eltek kornit digital mellanox technologies nova measuring instruments orbotech solaredge tower semiconductor security  defense arotech elbit systems ituran location and control magal security systems pointer telocation rada electronic industries tat technologies consumer goods caesarstone sdotyam sodastream international conglomerates ampalamerican israel corporation elbit imaging isramco this company is americanbased but is traded on the tase as a result of a merger with israeli drug maker agis retrieved from httpsenwikipediaorgwindexphptitlerosettagenomicsoldid categories biotechnology companiesbiotechnology companies of israelcompanies listed on nasdaqgenomics companies navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  may  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view rosetta genomics  wikipedia rosetta genomics from wikipedia the free encyclopedia jump to navigation search rosetta genomics type public nasdaq rosg industry biotechnology founded  founder dr isaac bentwich headquarters rehovot israel and jersey city us key people ken berlin president and ceo dr isaac bentwich founder products micrornabased diagnostic tests and therapeutics number of employees  as of  website wwwrosettagenomicscom rosetta genomics ltd is a molecular diagnostics company with offices in israel and the united states that uses microribonucleic acid microrna biomarkers to develop diagnostic tests designed to differentiate between various types of cancer the company expects the first three tests based on its technology to be submitted for regulatory approval in  the diagnostic tests will differentiate between squamous and nonsquamous nonsmall cell lung cancer nsclc differentiate between adenocarcinoma and peritoneal mesothelioma and seek to identify the origin of tumors in patients representing cancer of unknown primary cup using a single microrna the highly sensitive highly specific test for squamous and nonsquamous lung cancer has passed the prevalidation phase  and has been submitted for approval to the new york state department of health clinical laboratory evaluation program in april  in april  nature biotechnology published a study by rosetta genomics’ scientists whose findings demonstrate micrornas significant potential to act as effective biomarkers that may be applied in a diagnostic test designed to identify the primary tumor site in patients cup in addition to its diagnostic programs rosetta genomics is collaborating with isis pharmaceuticals to develop a micrornabased therapy for hepatocellular carcinoma hcc a form of liver cancer contents  intellectual property  platform technologies  licenses and collaborations  history  references  external links intellectual propertyedit rosetta genomics has developed a microrna discovery process combining powerful informatics with highthroughput biological techniques this has led to the discovery of a large portion of today’s known human and viral micrornas in  the us patent and trademark office issued rosetta genomics with two patents relating to micrornas in march  rosetta genomics announced that the us patent and trademark office has issued allowance for two of the companys patent applications on human and viral micrornas platform technologiesedit rosetta genomics has developed several proprietary technologies that enable the company to work with micrornas at the basis of these technologies are proprietary microrna extraction protocols that include sensitive extraction of micrornas from most body fluids including serum urine saliva with virtually no microrna lost in the extraction process the company has also developed a microrna extraction protocol from formalin fixed paraffin embedded or ffpe samples this allows extraction of micrornas from samples preserved at room temperature once micrornas are extracted rosetta genomics’ technology is capable of detecting and quantifying the micrornas using two custom designed platform technologies which utilize quantitative real time pcr or qrtpcr and microarrays the company’s proprietary microarray platform covers approximately  human micrornas including approximately  micrornas  which are rosetta genomics’ proprietary micrornas the array’s high specificity allows discriminating homologous family members licenses and collaborationsedit in january  rosetta genomics announced a collaboration agreement with the henry ford health system in detroit michigan to develop micrornabased diagnostics and prognostics for brain cancer also in january  rosetta genomics announced that its subsidiary rosetta genomics inc has received a license to use roche molecular systems pcr technology in micrornabased diagnostic tests in september  rosetta genomics said it will work with new york university medical center to develop a micrornabased diagnostic test for melanoma in may  rosetta genomics announced columbia university medical center would utilize its clinical laboratory improvement amendments cliacertified laboratory to perform the clinical validation of rosetta genomics’ diagnostics program for cancer of unknown primary in february  isis pharmaceuticals inc and rosetta genomics said they will collaborate to develop antisense drugs that inhibit microrna in the liver to treat cancers there antisense drugs are a class of compounds that interfere with genetic material that gets translated into harmful proteins historyedit rosetta genomics was founded by isaac bentwich in  to pursue commercial applications of microrna research the company had its ipo on march   and is traded on the nasdaq rosetta genomics expects the funds raised to advance its micrornabased diagnostic and therapeutic cancer products through initial clinical validation defined as success in identifying the specific biomarker panels via blinded tests of samples supplied by medical institutions referencesedit  chambers heather isis alnylam pair to seek diseasefighting drugs san diego business journal september    a b columbia university medical center and rosetta genomics announce columbia universitys submission of the first cancer diagnostic test based on rosetta genomics proprietary microrna technology for approval to the new york state department of health clinical laboratory evaluation program forbescom april    a b rosetta genomics ltd completes prevalidation phase for first diagnostic production reuters october    a b boggs jennifer rosetta genomics ipo raising m for microrna workbioworld today february    rosenfeld n aharonov r meiri e et al april  micrornas accurately identify cancer tissue origin pdf nat biotechnol   – pmid  doinbt   antisense oligonucleotide heptacellular carcinoma isisrosetta genomics isis rosetta genomics licensing agreement rd focus drug news march    bentwich i avniel a karov y et al july  identification of hundreds of conserved and nonconserved human micrornas pdf nat genet   – pmid  doing   httpmoneycnncomnewsnewsfeedsarticlesprnewswireprnewsusprukmhtm rosetta genomics announces expansion of its microrna intellectual property estate cnnmoneycom april    httpnewsmoneycentralmsncomproviderproviderarticleaspxfeedbcomdate idcideiptnmrzngoaklymcq market reportin play wires msnmoneycom march   httpwwwusptogovwebpatentspatogweekoghtmlushtml uspto web site uspto patent fulltext and image database  other news to note bioworld today april    henry ford hospital and rosetta genomics to develop micrornabased diagnostics for brain cancer company reports january    nanogen inc licenses mgb probe technology to rosetta genomics ltd reuters significant developments december    rosetta and rockefeller enter microrna agreement datamonitor news and comment june    business diary acquisitions crains detroit business february    httpwwwfdanewscomnewsletterarticlearticleidissueid rosetta genomics licenses roche pcr technology fdanews device daily bulletin january    everitt jay rosetta genomics ltdrosg to work in collaboration with nyu medical center knobias september    rosetta genomics ltd signs agreement with columbia university medical center reuters may    isis rosetta join on cancer treatment associated press february    httpwwwforbescombusinessforbeshtml herper matthew and robert langreth treasures in the trash forbes december    httpwwwhooverscomrosettagenomicsidfreecoprofilexhtml hoovers web site rosetta genomics company description  alnylam pharma shares rise on cantor fitgeralds microrna technology outlook associated press september   external linksedit company website v t e israeli companies traded on nasdaq healthcare alcobra biolinerx biondvax pharmaceutical compugen enzymotec given imaging kamada mazor robotics medigus oramed pharmaceuticals perrigo company pluristem therapeutics rewalk robotics rosetta genomics syneron medical communication  networks allot communications alvarion audiocodes b communications ceragon networks dsp group ezchip semiconductor gilat satellite networks internet gold golden lines orckit communications partner communications company radcom radvision rit technologies rr media software attunity bluephoenix solutions bos better online solutions check point software technologies clicksoftware technologies commtouch software cimatron cyberark formula systems  jacada magic software enterprises mind cti nice systems perion network radware sapiens international corporation nv verint systems wix electronics camtek ceva eltek kornit digital mellanox technologies nova measuring instruments orbotech solaredge tower semiconductor security  defense arotech elbit systems ituran location and control magal security systems pointer telocation rada electronic industries tat technologies consumer goods caesarstone sdotyam sodastream international conglomerates ampalamerican israel corporation elbit imaging isramco this company is americanbased but is traded on the tase as a result of a merger with israeli drug maker agis retrieved from httpsenwikipediaorgwindexphptitlerosettagenomicsoldid categories biotechnology companiesbiotechnology companies of israelcompanies listed on nasdaqgenomics companies navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  may  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view stockscountryunited states index  markets index bulletin investor alert london markets close in currencies futures metals stocks stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york open marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest apacking the pounds back on pigs abreakingfda says it plans to lower nicotine in cigarettes to nonaddictive levels adollar turns lower for the week following gdp report aset yourself up to get the most out of retirement atesla earnings will model  live up to the hype abitcoin prices rise as ether extends recent weakness atreasury yields dip after secondquarter gdp data anew rule forces big car makers into big changes in how they count revenues athese are the times you’re actually allowed to put money back into your ira aweekend sip is this the world’s first distilled nonalcoholic spirit aus gdp speeds up to  in nd quarter atime for gop to face reality everybody is going to have health insurance astock market edges lower on track for weekly losses ahoward marks says bitcoin isn’t real—and we can all blame millennials for its rise aminor lift for final consumer sentiment reading in july as partisan divide remains aus dollar holds decline after consumer sentiment data atreasury yields flat after consumer sentiment data afinal umich consumer sentiment for july was  abojangles shares sink after revenue miss guidance cut atreasury to wind down the myra retirement savings program loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert london markets close in currencies futures metals stocks stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york open marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest apacking the pounds back on pigs abreakingfda says it plans to lower nicotine in cigarettes to nonaddictive levels adollar turns lower for the week following gdp report aset yourself up to get the most out of retirement atesla earnings will model  live up to the hype abitcoin prices rise as ether extends recent weakness atreasury yields dip after secondquarter gdp data anew rule forces big car makers into big changes in how they count revenues athese are the times you’re actually allowed to put money back into your ira aweekend sip is this the world’s first distilled nonalcoholic spirit aus gdp speeds up to  in nd quarter atime for gop to face reality everybody is going to have health insurance astock market edges lower on track for weekly losses ahoward marks says bitcoin isn’t real—and we can all blame millennials for its rise aminor lift for final consumer sentiment reading in july as partisan divide remains aus dollar holds decline after consumer sentiment data atreasury yields flat after consumer sentiment data afinal umich consumer sentiment for july was  abojangles shares sink after revenue miss guidance cut atreasury to wind down the myra retirement savings program loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  rosg stock price  rosetta genomics ltd stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  nov  mo  gt  fls  mat  latest newsall times eastern a packing the pounds back on pigs a breaking fda says it plans to lower nicotine in cigarettes to nonaddictive levels a updated dollar turns lower for the week following gdp report a updated set yourself up to get the most out of retirement a updated tesla earnings will model  live up to the hype a bitcoin prices rise as ether extends recent weakness a updated treasury yields dip after secondquarter gdp data a updated new rule forces big car makers into big changes in how they count revenues a updated these are the times you’re actually allowed to put money back into your ira a updated weekend sip is this the world’s first distilled nonalcoholic spirit to be replaced home investing quotes stocks united states rosg overview compare quotes stock screener earnings calendar sectors nasdaq rosg us nasdaq join td ameritrade find a broker rosetta genomics ltd watchlist createrosgalert open last updated jul    am edt real time quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  last   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones yencarry reversal crushes stocks jan   at  pm et by anthony mirhaydari investors prepare to be disappointed jan   at  pm et by anthony mirhaydari monsanto buying israels rosetta green feb   at  pm et  bullish charts to watch sep   at  pm et by sinisa persich rosetta genomics jumps ahead of business update sep   at  pm et by val brickates kennedy thursday’s biggest gaining and declining stocks aug   at  pm et by marketwatch rosetta genomics shares soar  aug   at  pm et by val brickates kennedy a forest fire of reasons to prepare for the next crash right now aug   at  pm et by cody willard stocks to watch tuesday coinstar liberty media jun   at  am et by marketwatch rosetta climbs on board appointment jun   at  pm et by val brickates kennedy friday’s top gaining and declining stocks may   at  pm et by val brickates kennedy stocks to watch tuesday rosetta genomics may   at  pm et by david b wilkerson rosetta genomics to sell  discounted shares may   at  pm et rosetta genomics to cut  rd jobs oct   at  am et stocks to watch heinz constellation brands whole foods feb   at  am et on the wall street journal stocks to watch hewlettpackard guess big lots aug   at  am et on the wall street journal stocks to watch knight capital zipcar linkedin aug   at  am et on the wall street journal stocks to watch apollo group coinstar news corp jun   at  am et on the wall street journal stocks to watch frontline verifone systems talbots may   at  am et on the wall street journal recent news other news press releases rosetta genomics readies equity offering shares down  rosetta genomics readies equity offering shares down  jul   at  pm et on seeking alpha week ahead  fireworks on independence day and maybe at the g and qatar too week ahead  fireworks on independence day and maybe at the g and qatar too jul   at  am et on seeking alpha week ahead  wall streets keys week ahead  wall streets keys jun   at  am et on seeking alpha rosetta genomicss rosg ceo ken berlin on q  results  earnings call transcript mar   at  pm et on seeking alpha premarket gainers as of  am mar   at  am et on seeking alpha rosetta to raise m via equity and convertible debt shares down  nov   at  pm et on seeking alpha rosetta genomics inks deal to develop test to predict response to bristolmyers cancer drug opdivo nov   at  am et on seeking alpha rosetta genomicss rosg ceo ken berlin on q  results  earnings call transcript sep   at  pm et on seeking alpha biotech forum daily digest opko gets early fda approval zika virus again in the news spotlight on xbiotech jun   at  am et on seeking alpha rosettas dna tests for blood cancers conditionally approved in ny shares up  jun   at  am et on seeking alpha rosetta genomicss rosg ceo ken berlin on q  results  earnings call transcript may   at  pm et on seeking alpha  biotechnology stocks to sell now apr   at  am et on investorplacecom rosetta genomics rosg ceo ken berlin on q  results  earnings call transcript mar   at  pm et on seeking alpha ny clears rosettas thyroid cancer test shares up  feb   at  pm et on seeking alpha rosetta inks deal with national provider network covering all tests and services feb   at  pm et on seeking alpha rosetta genomics awarded patent related to kidney tumor gene expression jan   at  am et on seeking alpha  biotechnology stocks to sell now jan   at  am et on investorplacecom rosetta genomics sublicenses microrna patents to mirna therapeutics for m plus royalties jan   at  pm et on seeking alpha premarket biotech digest geron on the move repros tumbles globeimmune rumors dec   at  am et on seeking alpha  biotechnology stocks to sell now nov   at  am et on investorplacecom rosettagx revealtm to be highlighted in oral presentation at the rd world congress on thyroid cancer rosettagx revealtm to be highlighted in oral presentation at the rd world congress on thyroid cancer jul   at  am et on accesswire rosetta genomics expands patent portfolio in canada united states and china rosetta genomics expands patent portfolio in canada united states and china jul   at  am et on accesswire rosetta genomics granted european patent allowance covering rosettagx cancer origin assay rosetta genomics granted european patent allowance covering rosettagx cancer origin assay may   at  am et on accesswire rosetta genomics enters collaboration to develop a microrna classifier relating to patients with nonsmall cell lung cancer considered for treatment with immunooncology drugs rosetta genomics enters collaboration to develop a microrna classifier relating to patients with nonsmall cell lung cancer considered for treatment with immunooncology drugs may   at  am et on accesswire rosetta genomics focusing efforts on improving cash position through sale of the personalizedx business and monetizing ip rosetta genomics focusing efforts on improving cash position through sale of the personalizedx business and monetizing ip may   at  pm et on accesswire rosetta genomics announces favorable results from two pilot studies comparing rosettagx revealtm and the afirma gec assay for the classification of indeterminate thyroid nodules rosetta genomics announces favorable results from two pilot studies comparing rosettagx revealtm and the afirma gec assay for the classification of indeterminate thyroid nodules may   at  am et on accesswire rosetta genomics expands international access for rosettagx revealtm through agreement with cytolog laboratories in brazil rosetta genomics expands international access for rosettagx revealtm through agreement with cytolog laboratories in brazil may   at  am et on accesswire rosetta genomics receives final approval from new york state for firstofitskind thyroid cancer diagnostic assay rosetta genomics receives final approval from new york state for firstofitskind thyroid cancer diagnostic assay may   at  am et on accesswire rosetta genomics to increase investment in rosettagx revealtm and explore strategic alternatives for the personalizedx business rosetta genomics to increase investment in rosettagx revealtm and explore strategic alternatives for the personalizedx business may   at  am et on accesswire rosetta genomics expands patent portfolio in europe and japan rosetta genomics expands patent portfolio in europe and japan may   at  am et on accesswire new data highlighting the powerful performance of rosettagx revealtm in identifying medullary thyroid cancer to be presented at the aace  annual meeting apr   at  am et on accesswire rosetta genomics and halozyme therapeutics wait for better news mar   at  am et on accesswire rosetta genomics reports  fourth quarter and full year financial results mar   at  am et on accesswire rosetta genomics to host  fourth quarter and year end financial results and business update conference call on march   mar   at  am et on accesswire rosetta genomics fortifies patent protection for its unique rosettagx revealtm assay mar   at  am et on businesswire  bzx rosetta genomics announces for reverse stock split mar   at  pm et on businesswire  bzx rosetta genomics closes second tranche of previously announced private placement of convertible debentures feb   at  am et on businesswire  bzx rosetta genomics reports preliminary rosettagx reveal™ financial results for the  fourth quarter and year feb   at  am et on businesswire  bzx rosetta genomics announces key us patent allowances for two rosettagx revealtm micrornas feb   at  am et on businesswire  bzx rosetta genomics reports third quarter  financial results dec   at  am et on accesswire rosetta genomics ltd rosetta genomics ltd provides therapeutic diagnostic product development and medical research services the company develops and commercializes new diagnostic tests based on various genomics markers including dna microrna and protein biomarkers and using various technologies including qpcr microarrays next generation sequencing and fluorescence in situ hybridization it offers proprietary microrna technologies such as rosetta cancer origin mikidney and rosettagx reveal test the company was founded by isaac bentwich on march   and is headquartered in rehovot israel see full profile benzingas top initiations apr   at  am et on benzingacom barrington research initiates rosetta genomics with outperform apr   at  am et on benzingacom rosetta genomics shares upgraded at cantor apr   at  am et on benzingacom competitors name chg  market cap exact sciences corp  b genomic health inc  b trovagene inc  m teva pharmaceutical industries ltd adr  b genenews ltd  m competitor data provided by partner content trending tickers powered by amzn  sbux  bidu  xom  ktos  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience rosg sec filings  rosetta genomics ltd sec filings  marketwatch bulletin investor alert london markets close in currencies futures metals stocks expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close rosetta genomics ltd nasdaq rosg go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus rosetta genomics ltd market open  real time quotes jul    am rosg quoteszigmancomposite   change   volume volume  real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   show all k k q proxy registration d f g sec filings for rosetta genomics ltd getting started with sec filings filing date document date type category amended  na sc g institutional ownership  na sc d na  na sc ga institutional ownership   na sc ga institutional ownership   na sc g institutional ownership  na sc g institutional ownership  na s registration statement  na sc ga institutional ownership   na sc g institutional ownership  na sc ga institutional ownership   na sc ga institutional ownership   na sc ga institutional ownership   na sc g institutional ownership  na sc g institutional ownership  na sc g institutional ownership  na sc g institutional ownership  na sc g institutional ownership  na sc g institutional ownership  na sc ga institutional ownership   na sc ga institutional ownership  more sec filings provided by edgar online inc trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite tlt quoteszigmancomposite jnug x powered by log in  am edt july   marketstatecountryus new york open marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest apacking the pounds back on pigs abreakingfda says it plans to lower nicotine in cigarettes to nonaddictive levels adollar turns lower for the week following gdp report aset yourself up to get the most out of retirement atesla earnings will model  live up to the hype abitcoin prices rise as ether extends recent weakness atreasury yields dip after secondquarter gdp data anew rule forces big car makers into big changes in how they count revenues athese are the times you’re actually allowed to put money back into your ira aweekend sip is this the world’s first distilled nonalcoholic spirit aus gdp speeds up to  in nd quarter atime for gop to face reality everybody is going to have health insurance astock market edges lower on track for weekly losses ahoward marks says bitcoin isn’t real—and we can all blame millennials for its rise aminor lift for final consumer sentiment reading in july as partisan divide remains aus dollar holds decline after consumer sentiment data atreasury yields flat after consumer sentiment data afinal umich consumer sentiment for july was  abojangles shares sink after revenue miss guidance cut atreasury to wind down the myra retirement savings program loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  rosg stock price  rosetta genomics ltd stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  nov  mo  gt  fls  mat  latest newsall times eastern a packing the pounds back on pigs a breaking fda says it plans to lower nicotine in cigarettes to nonaddictive levels a updated dollar turns lower for the week following gdp report a updated set yourself up to get the most out of retirement a updated tesla earnings will model  live up to the hype a bitcoin prices rise as ether extends recent weakness a updated treasury yields dip after secondquarter gdp data a updated new rule forces big car makers into big changes in how they count revenues a updated these are the times you’re actually allowed to put money back into your ira a updated weekend sip is this the world’s first distilled nonalcoholic spirit to be replaced home investing quotes stocks united states rosg overview compare quotes stock screener earnings calendar sectors nasdaq rosg us nasdaq join td ameritrade find a broker rosetta genomics ltd watchlist createrosgalert open last updated jul    am edt real time quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  last   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones yencarry reversal crushes stocks jan   at  pm et by anthony mirhaydari investors prepare to be disappointed jan   at  pm et by anthony mirhaydari monsanto buying israels rosetta green feb   at  pm et  bullish charts to watch sep   at  pm et by sinisa persich rosetta genomics jumps ahead of business update sep   at  pm et by val brickates kennedy thursday’s biggest gaining and declining stocks aug   at  pm et by marketwatch rosetta genomics shares soar  aug   at  pm et by val brickates kennedy a forest fire of reasons to prepare for the next crash right now aug   at  pm et by cody willard stocks to watch tuesday coinstar liberty media jun   at  am et by marketwatch rosetta climbs on board appointment jun   at  pm et by val brickates kennedy friday’s top gaining and declining stocks may   at  pm et by val brickates kennedy stocks to watch tuesday rosetta genomics may   at  pm et by david b wilkerson rosetta genomics to sell  discounted shares may   at  pm et rosetta genomics to cut  rd jobs oct   at  am et stocks to watch heinz constellation brands whole foods feb   at  am et on the wall street journal stocks to watch hewlettpackard guess big lots aug   at  am et on the wall street journal stocks to watch knight capital zipcar linkedin aug   at  am et on the wall street journal stocks to watch apollo group coinstar news corp jun   at  am et on the wall street journal stocks to watch frontline verifone systems talbots may   at  am et on the wall street journal recent news other news press releases rosetta genomics readies equity offering shares down  rosetta genomics readies equity offering shares down  jul   at  pm et on seeking alpha week ahead  fireworks on independence day and maybe at the g and qatar too week ahead  fireworks on independence day and maybe at the g and qatar too jul   at  am et on seeking alpha week ahead  wall streets keys week ahead  wall streets keys jun   at  am et on seeking alpha rosetta genomicss rosg ceo ken berlin on q  results  earnings call transcript mar   at  pm et on seeking alpha premarket gainers as of  am mar   at  am et on seeking alpha rosetta to raise m via equity and convertible debt shares down  nov   at  pm et on seeking alpha rosetta genomics inks deal to develop test to predict response to bristolmyers cancer drug opdivo nov   at  am et on seeking alpha rosetta genomicss rosg ceo ken berlin on q  results  earnings call transcript sep   at  pm et on seeking alpha biotech forum daily digest opko gets early fda approval zika virus again in the news spotlight on xbiotech jun   at  am et on seeking alpha rosettas dna tests for blood cancers conditionally approved in ny shares up  jun   at  am et on seeking alpha rosetta genomicss rosg ceo ken berlin on q  results  earnings call transcript may   at  pm et on seeking alpha  biotechnology stocks to sell now apr   at  am et on investorplacecom rosetta genomics rosg ceo ken berlin on q  results  earnings call transcript mar   at  pm et on seeking alpha ny clears rosettas thyroid cancer test shares up  feb   at  pm et on seeking alpha rosetta inks deal with national provider network covering all tests and services feb   at  pm et on seeking alpha rosetta genomics awarded patent related to kidney tumor gene expression jan   at  am et on seeking alpha  biotechnology stocks to sell now jan   at  am et on investorplacecom rosetta genomics sublicenses microrna patents to mirna therapeutics for m plus royalties jan   at  pm et on seeking alpha premarket biotech digest geron on the move repros tumbles globeimmune rumors dec   at  am et on seeking alpha  biotechnology stocks to sell now nov   at  am et on investorplacecom rosettagx revealtm to be highlighted in oral presentation at the rd world congress on thyroid cancer rosettagx revealtm to be highlighted in oral presentation at the rd world congress on thyroid cancer jul   at  am et on accesswire rosetta genomics expands patent portfolio in canada united states and china rosetta genomics expands patent portfolio in canada united states and china jul   at  am et on accesswire rosetta genomics granted european patent allowance covering rosettagx cancer origin assay rosetta genomics granted european patent allowance covering rosettagx cancer origin assay may   at  am et on accesswire rosetta genomics enters collaboration to develop a microrna classifier relating to patients with nonsmall cell lung cancer considered for treatment with immunooncology drugs rosetta genomics enters collaboration to develop a microrna classifier relating to patients with nonsmall cell lung cancer considered for treatment with immunooncology drugs may   at  am et on accesswire rosetta genomics focusing efforts on improving cash position through sale of the personalizedx business and monetizing ip rosetta genomics focusing efforts on improving cash position through sale of the personalizedx business and monetizing ip may   at  pm et on accesswire rosetta genomics announces favorable results from two pilot studies comparing rosettagx revealtm and the afirma gec assay for the classification of indeterminate thyroid nodules rosetta genomics announces favorable results from two pilot studies comparing rosettagx revealtm and the afirma gec assay for the classification of indeterminate thyroid nodules may   at  am et on accesswire rosetta genomics expands international access for rosettagx revealtm through agreement with cytolog laboratories in brazil rosetta genomics expands international access for rosettagx revealtm through agreement with cytolog laboratories in brazil may   at  am et on accesswire rosetta genomics receives final approval from new york state for firstofitskind thyroid cancer diagnostic assay rosetta genomics receives final approval from new york state for firstofitskind thyroid cancer diagnostic assay may   at  am et on accesswire rosetta genomics to increase investment in rosettagx revealtm and explore strategic alternatives for the personalizedx business rosetta genomics to increase investment in rosettagx revealtm and explore strategic alternatives for the personalizedx business may   at  am et on accesswire rosetta genomics expands patent portfolio in europe and japan rosetta genomics expands patent portfolio in europe and japan may   at  am et on accesswire new data highlighting the powerful performance of rosettagx revealtm in identifying medullary thyroid cancer to be presented at the aace  annual meeting apr   at  am et on accesswire rosetta genomics and halozyme therapeutics wait for better news mar   at  am et on accesswire rosetta genomics reports  fourth quarter and full year financial results mar   at  am et on accesswire rosetta genomics to host  fourth quarter and year end financial results and business update conference call on march   mar   at  am et on accesswire rosetta genomics fortifies patent protection for its unique rosettagx revealtm assay mar   at  am et on businesswire  bzx rosetta genomics announces for reverse stock split mar   at  pm et on businesswire  bzx rosetta genomics closes second tranche of previously announced private placement of convertible debentures feb   at  am et on businesswire  bzx rosetta genomics reports preliminary rosettagx reveal™ financial results for the  fourth quarter and year feb   at  am et on businesswire  bzx rosetta genomics announces key us patent allowances for two rosettagx revealtm micrornas feb   at  am et on businesswire  bzx rosetta genomics reports third quarter  financial results dec   at  am et on accesswire rosetta genomics ltd rosetta genomics ltd provides therapeutic diagnostic product development and medical research services the company develops and commercializes new diagnostic tests based on various genomics markers including dna microrna and protein biomarkers and using various technologies including qpcr microarrays next generation sequencing and fluorescence in situ hybridization it offers proprietary microrna technologies such as rosetta cancer origin mikidney and rosettagx reveal test the company was founded by isaac bentwich on march   and is headquartered in rehovot israel see full profile benzingas top initiations apr   at  am et on benzingacom barrington research initiates rosetta genomics with outperform apr   at  am et on benzingacom rosetta genomics shares upgraded at cantor apr   at  am et on benzingacom competitors name chg  market cap exact sciences corp  b genomic health inc  b trovagene inc  m teva pharmaceutical industries ltd adr  b genenews ltd  m competitor data provided by partner content trending tickers powered by amzn  sbux  bidu  xom  ktos  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience rosgnasdaq cm stock quote  rosetta genomics ltd  bloomberg markets error could not add to watchlist x  watchlist rosetta genomics ltd rosgus nasdaq cm usd   as of  am edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap m usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry pharmaceuticals biotechnology  life sciences  price change  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later  rosetta genomics fortifies patent protection for its unique rosettagx revealtm assay  rosetta genomics announces for reverse stock split  rosetta genomics closes second tranche of previously announced private placement of convertible debentures  rosetta genomics reports preliminary rosettagx reveal™ financial results for the  fourth quarter and year  rosetta genomics announces key us patent allowances for two rosettagx revealtm micrornas there are currently no press releases for this ticker please check back later profile rosetta genomics ltd is a biomedical company that discovers and develops diagnostic and therapeutic products based on a recently discovered group of genes known as micrornas address  plaut streetrehovot israel phone  website wwwrosettagenomicscom executives board members kenneth a berlin ken presidentceo ron kalfus chief financial officer mark r willig chief commercial officer dganit bar chief scientific officer eti meiri vpresearch show more rosg options chain  rosetta genomics ltd options chain  marketwatch bulletin investor alert london markets close in currencies futures metals stocks expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close rosetta genomics ltd nasdaq rosg go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus rosetta genomics ltd market open  real time quotes jul    am rosg quoteszigmancomposite   change   volume volume  real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   option chain for rosetta genomics ltd inthemoney october  options october  options show hide calls puts expires october   symbol last change vol bid ask open int strike symbol last change vol bid ask open int  current price as of   am quote       quote      quote       quote      show all  hide all related links options center options screener options expiration calendar trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york open marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest apacking the pounds back on pigs abreakingfda says it plans to lower nicotine in cigarettes to nonaddictive levels adollar turns lower for the week following gdp report aset yourself up to get the most out of retirement atesla earnings will model  live up to the hype abitcoin prices rise as ether extends recent weakness atreasury yields dip after secondquarter gdp data anew rule forces big car makers into big changes in how they count revenues athese are the times you’re actually allowed to put money back into your ira aweekend sip is this the world’s first distilled nonalcoholic spirit aus gdp speeds up to  in nd quarter atime for gop to face reality everybody is going to have health insurance astock market edges lower on track for weekly losses ahoward marks says bitcoin isn’t real—and we can all blame millennials for its rise aminor lift for final consumer sentiment reading in july as partisan divide remains aus dollar holds decline after consumer sentiment data atreasury yields flat after consumer sentiment data afinal umich consumer sentiment for july was  abojangles shares sink after revenue miss guidance cut atreasury to wind down the myra retirement savings program loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  rosg insider trading  rosetta genomics ltd transactions  marketwatch bulletin investor alert london markets close in currencies futures metals stocks expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close rosetta genomics ltd nasdaq rosg go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus rosetta genomics ltd market open  real time quotes jul    am rosg quoteszigmancomposite   change   volume volume  real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   sorry there are no insider transactions for this symbol copyright  factset research systems inc all rights reserved source factset fundamentals transaction summary total insider purchases and sales reported to the sec data not available officers and executives mr kenneth a berlin president  chief executive officer mr ron kalfus chief financial officer dr eti meiri vice presidentresearch  development mr mark r willig chief commercial officer ms tatia troy vice presidentpeople strategy  development mr douglas sites executive vice presidentsales  marketing ms sigal russogueta controller ms ana c ward executive vplegal  corporate development mr brian a markison chairman mr gerald dogon independent director ms tal yaroneldar independent director dr david sidransky independent director dr joshua rosensweig independent director mr roy n davis independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york open marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest apacking the pounds back on pigs abreakingfda says it plans to lower nicotine in cigarettes to nonaddictive levels adollar turns lower for the week following gdp report aset yourself up to get the most out of retirement atesla earnings will model  live up to the hype abitcoin prices rise as ether extends recent weakness atreasury yields dip after secondquarter gdp data anew rule forces big car makers into big changes in how they count revenues athese are the times you’re actually allowed to put money back into your ira aweekend sip is this the world’s first distilled nonalcoholic spirit aus gdp speeds up to  in nd quarter atime for gop to face reality everybody is going to have health insurance astock market edges lower on track for weekly losses ahoward marks says bitcoin isn’t real—and we can all blame millennials for its rise aminor lift for final consumer sentiment reading in july as partisan divide remains aus dollar holds decline after consumer sentiment data atreasury yields flat after consumer sentiment data afinal umich consumer sentiment for july was  abojangles shares sink after revenue miss guidance cut atreasury to wind down the myra retirement savings program loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  rosg historical stock quotes  rosetta genomics ltd historical stock quotes  marketwatch bulletin investor alert london markets close in currencies futures metals stocks expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close rosetta genomics ltd nasdaq rosg go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus rosetta genomics ltd market open  real time quotes jul    am rosg quoteszigmancomposite   change   volume volume  real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   enter date historical quote for rosg thursday july   closing price open high low volume  unadjusted price  adjustment factor log in  am edt july   marketstatecountryus new york open marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest apacking the pounds back on pigs abreakingfda says it plans to lower nicotine in cigarettes to nonaddictive levels adollar turns lower for the week following gdp report aset yourself up to get the most out of retirement atesla earnings will model  live up to the hype abitcoin prices rise as ether extends recent weakness atreasury yields dip after secondquarter gdp data anew rule forces big car makers into big changes in how they count revenues athese are the times you’re actually allowed to put money back into your ira aweekend sip is this the world’s first distilled nonalcoholic spirit aus gdp speeds up to  in nd quarter atime for gop to face reality everybody is going to have health insurance astock market edges lower on track for weekly losses ahoward marks says bitcoin isn’t real—and we can all blame millennials for its rise aminor lift for final consumer sentiment reading in july as partisan divide remains aus dollar holds decline after consumer sentiment data atreasury yields flat after consumer sentiment data afinal umich consumer sentiment for july was  abojangles shares sink after revenue miss guidance cut atreasury to wind down the myra retirement savings program loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  rosg analyst estimates  rosetta genomics ltd analyst estimates  marketwatch bulletin investor alert london markets close in currencies futures metals stocks expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close rosetta genomics ltd nasdaq rosg go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus rosetta genomics ltd market open  real time quotes jul    am rosg quoteszigmancomposite   change   volume volume  real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   earnings summaries earnings scheduled for march    am march    benzingacom earnings scheduled for september    am sept    benzingacom midafternoon market update werner enterprises slides following weak guidance imperva shares spike higher  pm june    benzingacom analyst recommendations benzingas top initiations  am april    benzingacom barrington research initiates rosetta genomics with outperform  am april    benzingacom rosetta genomics shares upgraded at cantor  am april    benzingacom trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york open marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest apacking the pounds back on pigs abreakingfda says it plans to lower nicotine in cigarettes to nonaddictive levels adollar turns lower for the week following gdp report aset yourself up to get the most out of retirement atesla earnings will model  live up to the hype abitcoin prices rise as ether extends recent weakness atreasury yields dip after secondquarter gdp data anew rule forces big car makers into big changes in how they count revenues athese are the times you’re actually allowed to put money back into your ira aweekend sip is this the world’s first distilled nonalcoholic spirit aus gdp speeds up to  in nd quarter atime for gop to face reality everybody is going to have health insurance astock market edges lower on track for weekly losses ahoward marks says bitcoin isn’t real—and we can all blame millennials for its rise aminor lift for final consumer sentiment reading in july as partisan divide remains aus dollar holds decline after consumer sentiment data atreasury yields flat after consumer sentiment data afinal umich consumer sentiment for july was  abojangles shares sink after revenue miss guidance cut atreasury to wind down the myra retirement savings program loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  rosg  stock quote for rosetta genomics ltd  msn money msn back to msn home money web search sign in change language  content américa latina español argentina español australia english belgië nederlands belgique français brasil português canada english canada français chile español colombia español danmark dansk deutschland deutsch españa español france français india english indonesia bahasa indonesia ireland english italia italiano malaysia english méxico español nederland nederlands new zealand english norge norsk bokmål österreich deutsch perú español philippines english polska polski portugal português schweiz deutsch singapore english south africa english suisse français suomi suomi sverige svenska türkiye türkçe united arab emirates english united kingdom english united states english united states español venezuela español việt nam tiếng việt ελλάδα ελληνικά россия pусский ישראל עברית‏ الإمارات العربية المتحدة العربية‏ المملكة العربية السعودية العربية‏ مصر العربية‏ ไทย ไทย 한국 한국어      語   switch to latino español feedback help adchoices rosetta genomics ltd nasdaq rosg us markets open adchoices  ▲   after hours     july    am edt delayed  minutes source nasdaq currency in usd save summary financials analysis options ownership company history related open  previous close  volume avg k k days range  wk range  market cap m dividend rate  yield  beta  shares outstanding m pe ratio eps  recent news rosetta genomics expands patent portfolio in canada united states and china morning star  rosetta genomics ltd rosg medical equipment deals and alliances profile report updated  prices from usd  bioportfoliocom  hrs ago morning initial report composite index recap of daily losers july  fx pips  day ago us stocks on the move boeing healthcare services stocks att times of india  day ago rosetta genomics usa  rosettagx reveal™ to be highlighted in oral presentation at the rd world congress on thyroid cancer  traders  days ago rosettagx revealtm to be highlighted in oral presentation at the rd world congress on thyroid cancer baystreet  days ago personalized medicines market  key trends and forecast research report  openprcom  days ago rosetta genomics rosg stock rosg stock marketsinsidercom  prostate cancer screening market to witness comprehensive growth by  –  mynewsdeskcom  independence advisors llc buys shares of  alexion pharmaceuticals inc nasdaqalxn ismboardcom  in volatile markets do analysts think you should buy rosetta genomics ltd rosg desotoedgecom  gaps are down for these companies today – rosg tkat carv osul msm aldr virt fx pips  rosetta genomics expands patent portfolio in canada united states and china baystreet  rosetta genomics nasdaqrosg getting favorable media coverage report shows bns  apple inc nasdaqaapl made it easier to connect carekit apps to hospital backends benchmarkmonitorcom  rosetta genomics rosg given coverage optimism rating of  themarketsdailycom  rosetta genomics rosg given daily news impact rating of  themarketsdailycom  rosetta genomics rosg receiving somewhat favorable media coverage study shows breeze  adchoices adchoices adchoices markets dow dow ▼    last updated time   am edt markets nasdaq nasdaq ▼    ftse  ftse  ▼    nyse composite nyse composite ▼    adchoices feedback send feedback provide feedback report a problem we appreciate your input select a category im having problems with top destinations im having issues searching im having problems with featured apps i see an error in the content other how we can improve please give an overall site rating submit close privacy statement help help  support rosetta genomics  wikipedia rosetta genomics from wikipedia the free encyclopedia jump to navigation search rosetta genomics type public nasdaq rosg industry biotechnology founded  founder dr isaac bentwich headquarters rehovot israel and jersey city us key people ken berlin president and ceo dr isaac bentwich founder products micrornabased diagnostic tests and therapeutics number of employees  as of  website wwwrosettagenomicscom rosetta genomics ltd is a molecular diagnostics company with offices in israel and the united states that uses microribonucleic acid microrna biomarkers to develop diagnostic tests designed to differentiate between various types of cancer the company expects the first three tests based on its technology to be submitted for regulatory approval in  the diagnostic tests will differentiate between squamous and nonsquamous nonsmall cell lung cancer nsclc differentiate between adenocarcinoma and peritoneal mesothelioma and seek to identify the origin of tumors in patients representing cancer of unknown primary cup using a single microrna the highly sensitive highly specific test for squamous and nonsquamous lung cancer has passed the prevalidation phase  and has been submitted for approval to the new york state department of health clinical laboratory evaluation program in april  in april  nature biotechnology published a study by rosetta genomics’ scientists whose findings demonstrate micrornas significant potential to act as effective biomarkers that may be applied in a diagnostic test designed to identify the primary tumor site in patients cup in addition to its diagnostic programs rosetta genomics is collaborating with isis pharmaceuticals to develop a micrornabased therapy for hepatocellular carcinoma hcc a form of liver cancer contents  intellectual property  platform technologies  licenses and collaborations  history  references  external links intellectual propertyedit rosetta genomics has developed a microrna discovery process combining powerful informatics with highthroughput biological techniques this has led to the discovery of a large portion of today’s known human and viral micrornas in  the us patent and trademark office issued rosetta genomics with two patents relating to micrornas in march  rosetta genomics announced that the us patent and trademark office has issued allowance for two of the companys patent applications on human and viral micrornas platform technologiesedit rosetta genomics has developed several proprietary technologies that enable the company to work with micrornas at the basis of these technologies are proprietary microrna extraction protocols that include sensitive extraction of micrornas from most body fluids including serum urine saliva with virtually no microrna lost in the extraction process the company has also developed a microrna extraction protocol from formalin fixed paraffin embedded or ffpe samples this allows extraction of micrornas from samples preserved at room temperature once micrornas are extracted rosetta genomics’ technology is capable of detecting and quantifying the micrornas using two custom designed platform technologies which utilize quantitative real time pcr or qrtpcr and microarrays the company’s proprietary microarray platform covers approximately  human micrornas including approximately  micrornas  which are rosetta genomics’ proprietary micrornas the array’s high specificity allows discriminating homologous family members licenses and collaborationsedit in january  rosetta genomics announced a collaboration agreement with the henry ford health system in detroit michigan to develop micrornabased diagnostics and prognostics for brain cancer also in january  rosetta genomics announced that its subsidiary rosetta genomics inc has received a license to use roche molecular systems pcr technology in micrornabased diagnostic tests in september  rosetta genomics said it will work with new york university medical center to develop a micrornabased diagnostic test for melanoma in may  rosetta genomics announced columbia university medical center would utilize its clinical laboratory improvement amendments cliacertified laboratory to perform the clinical validation of rosetta genomics’ diagnostics program for cancer of unknown primary in february  isis pharmaceuticals inc and rosetta genomics said they will collaborate to develop antisense drugs that inhibit microrna in the liver to treat cancers there antisense drugs are a class of compounds that interfere with genetic material that gets translated into harmful proteins historyedit rosetta genomics was founded by isaac bentwich in  to pursue commercial applications of microrna research the company had its ipo on march   and is traded on the nasdaq rosetta genomics expects the funds raised to advance its micrornabased diagnostic and therapeutic cancer products through initial clinical validation defined as success in identifying the specific biomarker panels via blinded tests of samples supplied by medical institutions referencesedit  chambers heather isis alnylam pair to seek diseasefighting drugs san diego business journal september    a b columbia university medical center and rosetta genomics announce columbia universitys submission of the first cancer diagnostic test based on rosetta genomics proprietary microrna technology for approval to the new york state department of health clinical laboratory evaluation program forbescom april    a b rosetta genomics ltd completes prevalidation phase for first diagnostic production reuters october    a b boggs jennifer rosetta genomics ipo raising m for microrna workbioworld today february    rosenfeld n aharonov r meiri e et al april  micrornas accurately identify cancer tissue origin pdf nat biotechnol   – pmid  doinbt   antisense oligonucleotide heptacellular carcinoma isisrosetta genomics isis rosetta genomics licensing agreement rd focus drug news march    bentwich i avniel a karov y et al july  identification of hundreds of conserved and nonconserved human micrornas pdf nat genet   – pmid  doing   httpmoneycnncomnewsnewsfeedsarticlesprnewswireprnewsusprukmhtm rosetta genomics announces expansion of its microrna intellectual property estate cnnmoneycom april    httpnewsmoneycentralmsncomproviderproviderarticleaspxfeedbcomdate idcideiptnmrzngoaklymcq market reportin play wires msnmoneycom march   httpwwwusptogovwebpatentspatogweekoghtmlushtml uspto web site uspto patent fulltext and image database  other news to note bioworld today april    henry ford hospital and rosetta genomics to develop micrornabased diagnostics for brain cancer company reports january    nanogen inc licenses mgb probe technology to rosetta genomics ltd reuters significant developments december    rosetta and rockefeller enter microrna agreement datamonitor news and comment june    business diary acquisitions crains detroit business february    httpwwwfdanewscomnewsletterarticlearticleidissueid rosetta genomics licenses roche pcr technology fdanews device daily bulletin january    everitt jay rosetta genomics ltdrosg to work in collaboration with nyu medical center knobias september    rosetta genomics ltd signs agreement with columbia university medical center reuters may    isis rosetta join on cancer treatment associated press february    httpwwwforbescombusinessforbeshtml herper matthew and robert langreth treasures in the trash forbes december    httpwwwhooverscomrosettagenomicsidfreecoprofilexhtml hoovers web site rosetta genomics company description  alnylam pharma shares rise on cantor fitgeralds microrna technology outlook associated press september   external linksedit company website v t e israeli companies traded on nasdaq healthcare alcobra biolinerx biondvax pharmaceutical compugen enzymotec given imaging kamada mazor robotics medigus oramed pharmaceuticals perrigo company pluristem therapeutics rewalk robotics rosetta genomics syneron medical communication  networks allot communications alvarion audiocodes b communications ceragon networks dsp group ezchip semiconductor gilat satellite networks internet gold golden lines orckit communications partner communications company radcom radvision rit technologies rr media software attunity bluephoenix solutions bos better online solutions check point software technologies clicksoftware technologies commtouch software cimatron cyberark formula systems  jacada magic software enterprises mind cti nice systems perion network radware sapiens international corporation nv verint systems wix electronics camtek ceva eltek kornit digital mellanox technologies nova measuring instruments orbotech solaredge tower semiconductor security  defense arotech elbit systems ituran location and control magal security systems pointer telocation rada electronic industries tat technologies consumer goods caesarstone sdotyam sodastream international conglomerates ampalamerican israel corporation elbit imaging isramco this company is americanbased but is traded on the tase as a result of a merger with israeli drug maker agis retrieved from httpsenwikipediaorgwindexphptitlerosettagenomicsoldid categories biotechnology companiesbiotechnology companies of israelcompanies listed on nasdaqgenomics companies navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  may  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view rosetta genomics  wikipedia rosetta genomics from wikipedia the free encyclopedia jump to navigation search rosetta genomics type public nasdaq rosg industry biotechnology founded  founder dr isaac bentwich headquarters rehovot israel and jersey city us key people ken berlin president and ceo dr isaac bentwich founder products micrornabased diagnostic tests and therapeutics number of employees  as of  website wwwrosettagenomicscom rosetta genomics ltd is a molecular diagnostics company with offices in israel and the united states that uses microribonucleic acid microrna biomarkers to develop diagnostic tests designed to differentiate between various types of cancer the company expects the first three tests based on its technology to be submitted for regulatory approval in  the diagnostic tests will differentiate between squamous and nonsquamous nonsmall cell lung cancer nsclc differentiate between adenocarcinoma and peritoneal mesothelioma and seek to identify the origin of tumors in patients representing cancer of unknown primary cup using a single microrna the highly sensitive highly specific test for squamous and nonsquamous lung cancer has passed the prevalidation phase  and has been submitted for approval to the new york state department of health clinical laboratory evaluation program in april  in april  nature biotechnology published a study by rosetta genomics’ scientists whose findings demonstrate micrornas significant potential to act as effective biomarkers that may be applied in a diagnostic test designed to identify the primary tumor site in patients cup in addition to its diagnostic programs rosetta genomics is collaborating with isis pharmaceuticals to develop a micrornabased therapy for hepatocellular carcinoma hcc a form of liver cancer contents  intellectual property  platform technologies  licenses and collaborations  history  references  external links intellectual propertyedit rosetta genomics has developed a microrna discovery process combining powerful informatics with highthroughput biological techniques this has led to the discovery of a large portion of today’s known human and viral micrornas in  the us patent and trademark office issued rosetta genomics with two patents relating to micrornas in march  rosetta genomics announced that the us patent and trademark office has issued allowance for two of the companys patent applications on human and viral micrornas platform technologiesedit rosetta genomics has developed several proprietary technologies that enable the company to work with micrornas at the basis of these technologies are proprietary microrna extraction protocols that include sensitive extraction of micrornas from most body fluids including serum urine saliva with virtually no microrna lost in the extraction process the company has also developed a microrna extraction protocol from formalin fixed paraffin embedded or ffpe samples this allows extraction of micrornas from samples preserved at room temperature once micrornas are extracted rosetta genomics’ technology is capable of detecting and quantifying the micrornas using two custom designed platform technologies which utilize quantitative real time pcr or qrtpcr and microarrays the company’s proprietary microarray platform covers approximately  human micrornas including approximately  micrornas  which are rosetta genomics’ proprietary micrornas the array’s high specificity allows discriminating homologous family members licenses and collaborationsedit in january  rosetta genomics announced a collaboration agreement with the henry ford health system in detroit michigan to develop micrornabased diagnostics and prognostics for brain cancer also in january  rosetta genomics announced that its subsidiary rosetta genomics inc has received a license to use roche molecular systems pcr technology in micrornabased diagnostic tests in september  rosetta genomics said it will work with new york university medical center to develop a micrornabased diagnostic test for melanoma in may  rosetta genomics announced columbia university medical center would utilize its clinical laboratory improvement amendments cliacertified laboratory to perform the clinical validation of rosetta genomics’ diagnostics program for cancer of unknown primary in february  isis pharmaceuticals inc and rosetta genomics said they will collaborate to develop antisense drugs that inhibit microrna in the liver to treat cancers there antisense drugs are a class of compounds that interfere with genetic material that gets translated into harmful proteins historyedit rosetta genomics was founded by isaac bentwich in  to pursue commercial applications of microrna research the company had its ipo on march   and is traded on the nasdaq rosetta genomics expects the funds raised to advance its micrornabased diagnostic and therapeutic cancer products through initial clinical validation defined as success in identifying the specific biomarker panels via blinded tests of samples supplied by medical institutions referencesedit  chambers heather isis alnylam pair to seek diseasefighting drugs san diego business journal september    a b columbia university medical center and rosetta genomics announce columbia universitys submission of the first cancer diagnostic test based on rosetta genomics proprietary microrna technology for approval to the new york state department of health clinical laboratory evaluation program forbescom april    a b rosetta genomics ltd completes prevalidation phase for first diagnostic production reuters october    a b boggs jennifer rosetta genomics ipo raising m for microrna workbioworld today february    rosenfeld n aharonov r meiri e et al april  micrornas accurately identify cancer tissue origin pdf nat biotechnol   – pmid  doinbt   antisense oligonucleotide heptacellular carcinoma isisrosetta genomics isis rosetta genomics licensing agreement rd focus drug news march    bentwich i avniel a karov y et al july  identification of hundreds of conserved and nonconserved human micrornas pdf nat genet   – pmid  doing   httpmoneycnncomnewsnewsfeedsarticlesprnewswireprnewsusprukmhtm rosetta genomics announces expansion of its microrna intellectual property estate cnnmoneycom april    httpnewsmoneycentralmsncomproviderproviderarticleaspxfeedbcomdate idcideiptnmrzngoaklymcq market reportin play wires msnmoneycom march   httpwwwusptogovwebpatentspatogweekoghtmlushtml uspto web site uspto patent fulltext and image database  other news to note bioworld today april    henry ford hospital and rosetta genomics to develop micrornabased diagnostics for brain cancer company reports january    nanogen inc licenses mgb probe technology to rosetta genomics ltd reuters significant developments december    rosetta and rockefeller enter microrna agreement datamonitor news and comment june    business diary acquisitions crains detroit business february    httpwwwfdanewscomnewsletterarticlearticleidissueid rosetta genomics licenses roche pcr technology fdanews device daily bulletin january    everitt jay rosetta genomics ltdrosg to work in collaboration with nyu medical center knobias september    rosetta genomics ltd signs agreement with columbia university medical center reuters may    isis rosetta join on cancer treatment associated press february    httpwwwforbescombusinessforbeshtml herper matthew and robert langreth treasures in the trash forbes december    httpwwwhooverscomrosettagenomicsidfreecoprofilexhtml hoovers web site rosetta genomics company description  alnylam pharma shares rise on cantor fitgeralds microrna technology outlook associated press september   external linksedit company website v t e israeli companies traded on nasdaq healthcare alcobra biolinerx biondvax pharmaceutical compugen enzymotec given imaging kamada mazor robotics medigus oramed pharmaceuticals perrigo company pluristem therapeutics rewalk robotics rosetta genomics syneron medical communication  networks allot communications alvarion audiocodes b communications ceragon networks dsp group ezchip semiconductor gilat satellite networks internet gold golden lines orckit communications partner communications company radcom radvision rit technologies rr media software attunity bluephoenix solutions bos better online solutions check point software technologies clicksoftware technologies commtouch software cimatron cyberark formula systems  jacada magic software enterprises mind cti nice systems perion network radware sapiens international corporation nv verint systems wix electronics camtek ceva eltek kornit digital mellanox technologies nova measuring instruments orbotech solaredge tower semiconductor security  defense arotech elbit systems ituran location and control magal security systems pointer telocation rada electronic industries tat technologies consumer goods caesarstone sdotyam sodastream international conglomerates ampalamerican israel corporation elbit imaging isramco this company is americanbased but is traded on the tase as a result of a merger with israeli drug maker agis retrieved from httpsenwikipediaorgwindexphptitlerosettagenomicsoldid categories biotechnology companiesbiotechnology companies of israelcompanies listed on nasdaqgenomics companies navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  may  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view stocks index  markets index bulletin investor alert london markets close in currencies futures metals stocks stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york open marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest apacking the pounds back on pigs abreakingfda says it plans to lower nicotine in cigarettes to nonaddictive levels adollar turns lower for the week following gdp report aset yourself up to get the most out of retirement atesla earnings will model  live up to the hype abitcoin prices rise as ether extends recent weakness atreasury yields dip after secondquarter gdp data anew rule forces big car makers into big changes in how they count revenues athese are the times you’re actually allowed to put money back into your ira aweekend sip is this the world’s first distilled nonalcoholic spirit aus gdp speeds up to  in nd quarter atime for gop to face reality everybody is going to have health insurance astock market edges lower on track for weekly losses ahoward marks says bitcoin isn’t real—and we can all blame millennials for its rise aminor lift for final consumer sentiment reading in july as partisan divide remains aus dollar holds decline after consumer sentiment data atreasury yields flat after consumer sentiment data afinal umich consumer sentiment for july was  abojangles shares sink after revenue miss guidance cut atreasury to wind down the myra retirement savings program loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  rosetta genomics ltd rosg  product pipeline analysis  update about us solutions resources ebookswhite papers slideshares videos blog contact us register log in my account logout browse research my cart menu   close   x browse about us solutions resources contact us log out register log in company reports»r  companies rosetta genomics ltd rosg  product pipeline analysis  update lowest prices guaranteed length publisher published date sku from   pages globaldata august  gbdt lowest prices guaranteed price from  length  pages publisher globaldata published date august  sku gbdt table of contents close window table of contents rosetta genomics ltd rosg  product pipeline analysis  update printer format globaldata rosetta genomics ltd company snapshot rosetta genomics ltd company overview rosetta genomics ltd pipeline products and clinical trials overview rosetta genomics ltd – pipeline analysis overview key facts rosetta genomics ltd  major products and services rosetta genomics ltd pipeline products by development stage rosetta genomics ltd pipeline products overview body fluidsbased diagnostic test  cancer body fluidsbased diagnostic test  cancer product overview microrna test  alzheimer’s disease microrna test  alzheimer’s disease product overview microrna test  bladder cancer risk stratification microrna test  bladder cancer risk stratification product overview microrna test  endometrial cancer stratification microrna test  endometrial cancer stratification product overview microrna test  gastric cancer recurrence microrna test  gastric cancer recurrence product overview microrna test  heart failure microrna test  heart failure product overview microrna test  ovarian cancer microrna test  ovarian cancer product overview microrna test  preeclampsia microrna test  preeclampsia product overview micrornabased assay  chronic allograft dysfunction micrornabased assay  chronic allograft dysfunction product overview micrornabased assay  neuromuscular diseases micrornabased assay  neuromuscular diseases product overview micrornabased assay  neuromuscular dystrophies micrornabased assay  neuromuscular dystrophies product overview micrornabased diagnostic test  melanoma micrornabased diagnostic test  melanoma product overview mirscreen test  colon cancer mirscreen test  colon cancer product overview prelude dcis  breast cancer prelude dcis  breast cancer product overview ros lung cancer biomarker ros lung cancer biomarker product overview rosetta genomics ltd  key competitors rosetta genomics ltd  key employees rosetta genomics ltd  locations and subsidiaries head office other locations  subsidiaries recent developments rosetta genomics ltd recent developments aug   rosetta expands managed care coverage with new preferred provider agreement with galaxy health network for entire suite of diagnostic tests and services jul   rosetta genomics receives us patent allowance for micrornabased ovarian cancer treatment jun   rosetta expands managed care coverage with new preferred provider agreement for entire suite of diagnostic tests and services jun   rosetta genomics receives approval from new york state for heme fishbased assays may   rosetta genomics announces publication of data confirming analytical validity of its novel thyroid nodule classification assay may   rosetta genomics receives approval from new york state for four pcrbased assays may   rosetta genomics reports  first quarter financial results mar   rosetta genomics reports  full year financial results feb   rosetta genomics appoints ana c ward as executive vice president legal and corporate development feb   rosetta genomics receives approval from new york state for firstofitskind thyroid cancer diagnostic assay appendix methodology about globaldata contact us disclaimer list of tablesrosetta genomics ltd pipeline products and clinical trials overview rosetta genomics ltd pipeline products by equipment type rosetta genomics ltd pipeline products by indication rosetta genomics ltd key facts rosetta genomics ltd major products and services rosetta genomics ltd number of pipeline products by development stage rosetta genomics ltd pipeline products summary by development stage body fluidsbased diagnostic test  cancer  product status body fluidsbased diagnostic test  cancer  product description microrna test  alzheimer’s disease  product status microrna test  alzheimer’s disease  product description microrna test  bladder cancer risk stratification  product status microrna test  bladder cancer risk stratification  product description microrna test  endometrial cancer stratification  product status microrna test  endometrial cancer stratification  product description microrna test  gastric cancer recurrence  product status microrna test  gastric cancer recurrence  product description microrna test  heart failure  product status microrna test  heart failure  product description microrna test  ovarian cancer  product status microrna test  ovarian cancer  product description microrna test  preeclampsia  product status microrna test  preeclampsia  product description micrornabased assay  chronic allograft dysfunction  product status micrornabased assay  chronic allograft dysfunction  product description micrornabased assay  neuromuscular diseases  product status micrornabased assay  neuromuscular diseases  product description micrornabased assay  neuromuscular dystrophies  product status micrornabased assay  neuromuscular dystrophies  product description micrornabased diagnostic test  melanoma  product status micrornabased diagnostic test  melanoma  product description mirscreen test  colon cancer  product status mirscreen test  colon cancer  product description prelude dcis  breast cancer  product status prelude dcis  breast cancer  product description ros lung cancer biomarker  product status ros lung cancer biomarker  product description rosetta genomics ltd key employees rosetta genomics ltd other locations rosetta genomics ltd subsidiaries list of figuresrosetta genomics ltd pipeline products by equipment type rosetta genomics ltd pipeline products by development stage description close window description rosetta genomics ltd rosg  product pipeline analysis  update printer format globaldata summaryrosetta genomics ltd rgl is a biotechnology company that develops next generation diagnostic tests for personalized medicine the company offers testing services such as cancer origin nextgen thyroid lung prostate bladder breast kidney and specialty tests it is developing tests for thyroid neoplasia oncology kidney rejection alzheimers disease therapeutics and cmv the company offers rosettagx platform on the cutting edge of molecular science and genomic testing technologies with tests it has presence in australia new zealand israel singapore canada greece india saudi arabia qatar the uae israel and turkey rgl is headquartered in rehovot israelthis report is a source for data analysis and actionable intelligence on the company’s portfolio of pipeline products the report provides key information about the company its major products and brands the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantagescopethe report reviews detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developmentsthe report analyzes all pipeline products in development for the company rosetta genomics ltdthe report provides pipeline analysis on all pipeline products of the company by equipment type by indication by development stage and by trial statusthe report covers detailed information on each pipeline product with information on pipeline territory stage of development device class regulatory path indications applications and estimated launch datethe report provides detailed description of products in development technical specification and functionsthe report also covers ongoing clinical trials wherever applicable with information on trial name trial objective sponsor trial design  trial status and phase estimated start and end datereasons to buydevelop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscapedesign and develop your product development marketing and sales strategies by understanding the competitor portfolioto formulate effective research  development strategiesdevelop marketentry and market expansion strategiesexploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust returnplan mergers and acquisitions effectively by identifying key players of the most promising pipeline identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantagedevelop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials stage and of development etcidentify understand and capitalize the next highvalue products that your competitor would add in its portfolio search inside this report close window search inside this report online download  purchase site license  purchase global site license  purchase   research assistance us  intl  download our ebook how to succeed using market research learn how to effectively navigate the market research process to help guide your organization on the journey to success download ebook share this report other tasks printer format order by fax currency converter rosg key statistics  rosetta genomics ltd financial ratios  marketwatch bulletin investor alert london markets close in currencies futures metals stocks expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close rosetta genomics ltd nasdaq rosg go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus rosetta genomics ltd market open  real time quotes jul    am rosg quoteszigmancomposite   change   volume volume  real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   company description rosetta genomics ltd provides therapeutic diagnostic product development and medical research services the company develops and commercializes new diagnostic tests based on various genomics markers including dna microrna and protein biomarkers and using various technologies including qpcr mi rosetta genomics ltd provides therapeutic diagnostic product development and medical research services the company develops and commercializes new diagnostic tests based on various genomics markers including dna microrna and protein biomarkers and using various technologies including qpcr microarrays next generation sequencing and fluorescence in situ hybridization it offers proprietary microrna technologies such as rosetta cancer origin mikidney and rosettagx reveal test the company was founded by isaac bentwich on march   and is headquartered in rehovot israel valuation pe current  pe ratio with extraordinary items  price to sales ratio  price to book ratio  enterprise value to ebitda  enterprise value to sales  total debt to enterprise value  efficiency revenueemployee  income per employee  receivables turnover  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure total debt to total equity  total debt to total capital  total debt to total assets  longterm debt to equity  longterm debt to total capital  officers and executives name age officer since title mr kenneth a berlin   president  chief executive officer mr ron kalfus   chief financial officer dr eti meiri   vice presidentresearch  development mr mark r willig   chief commercial officer ms tatia troy   vice presidentpeople strategy  development insider actions – purchase – sale  – number of transactions  except as otherwise noted the content of this page is licensed under the creative commons attribution  license and code samples are licensed under the apache  license for details see our site policies java is a registered trademark of oracle andor its affiliates last updated february   send feedback about this page documentation feedback freebase api deprecated product feedback cancel rosetta genomics ltd rosg  product pipeline analysis  update market segments size trend and market projections for upcoming years salesmarketresearchreportsbiz      home medical devices medical equipments rosetta genomics ltd rosg  product pipeline analysis  update rosetta genomics ltd rosg  product pipeline analysis  update  pages globaldata   in stock description table of contents related reports request sample rosetta genomics ltd rgl is a biotechnology company the company discovers develops and commercializes next generation diagnostic tests for personalized medicine its products under clinical development include mirview rosetta mesothelioma test rosetta cancer origin test rosetta lung cancer test and rosetta kidney cancer test rgl offers services such as testing services gene expression micrornabased diagnostic tests and identification and quantification of micrornas the company maintains business development division it has distribution network in australia new zealand singapore canada greece india saudi arabia qatar the uae israel and turkey the company has its presence in the ua rgl is headquartered in rehovot israel this report is a source for data analysis and actionable intelligence on the rosetta genomics ltd portfolio of pipeline products the report provides detailed analysis on each pipeline product with information on the indication the development stage trial phase product milestones pipeline territory estimated approval date and estimated launch date each pipeline product is profiled to cover information on product description function technology indication and application the report is also supplemented with a detailed company profile and information on clinical trials wherever applicable this report is built using data and information sourced from proprietary databases primary and secondary research and inhouse analysis by globaldatas team of industry experts scope detailed company profile with information on business description key company facts major products and services key competitors key employees locations and subsidiaries and recent developments detailed coverage on all the pipeline products by equipment type by therapy area by development stage and by trial phase information on product milestones and pipeline territory for each product the estimated approval date and estimated launch date profile of each pipeline product with additional information on product description function technology indications and application data on relevant clinical trials and product patent details wherever applicable information on clinical trial wherever applicable is supplemented with information on trial phase trial status trial objective trial design target patients unique physician identifier primary point secondary point acronym participants inclusion participants exclusion interventions trial results trial start date trial end date study type trial site trial funding age eligibility and gender eligibility reasons to buy develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally design and develop your product development marketing and sales strategies exploit ma opportunities by identifying market players with the most innovative pipeline develop marketentry and market expansion strategies exploit inlicensing and outlicensing opportunities by identifying products most likely to ensure a robust return identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials stage and phase of development etc which are the next highvalue products that your competitor would add in its portfolio identify understand and capitalize table of contents table of contents list of tables list of figures  key facts rosetta genomics ltd  major products and services rosetta genomics ltd pipeline products by equipment type rosetta genomics ltd pipeline products by development stage rosetta genomics ltd pipeline products by therapy area rosetta genomics ltd pipeline products by milestone summary body fluidsbased diagnostic test  cancer body fluidsbased diagnostic test  cancer product status body fluidsbased diagnostic test  cancer product description body fluidsbased diagnostic test  cancer product patent details diagnostic test  melanoma diagnostic test  melanoma product status diagnostic test  melanoma product description product institution details microrna test  congestive heart failure microrna test  congestive heart failure product status microrna test  congestive heart failure product description microrna test  congestive heart failure product patent details microrna test  gastric cancer recurrence microrna test  gastric cancer recurrence product status microrna test  gastric cancer recurrence product description microrna test  gastric cancer recurrence product milestone microrna test  gastric cancer recurrence product patent details microrna test  neurodegenerative disease microrna test  neurodegenerative disease product status microrna test  neurodegenerative disease product description microrna test  neurodegenerative disease product patent details microrna test  ovarian cancer microrna test  ovarian cancer product status microrna test  ovarian cancer product description microrna test  ovarian cancer product milestone microrna test  ovarian cancer product patent details microrna test  preeclampsia microrna test  preeclampsia product status microrna test  preeclampsia product description microrna test  preeclampsia product patent details mirscreen test  colon cancer mirscreen test  colon cancer product status mirscreen test  colon cancer product description mirscreen test  colon cancer product milestone mirview test  bladder cancer mirview test  bladder cancer product status mirview test  bladder cancer product description rosetta genomics ltd  key competitors rosetta genomics ltd  key employees rosetta genomics ltd  locations and subsidiaries head office recent developments rosetta genomics ltd recent developments sep   rosetta genomics to participate at the aegis capital  healthcare conference sep   rosetta genomics cancer origin test highlighted on the dr steve show sep   rosetta genomics reports financial results for the first six months of  sep   rosetta genomics executes credentialing agreements with two national healthcare preferred provider networks sep   rosetta genomics to host business update conference call on september   aug   rosetta genomics and ramot at tel aviv university awarded grant from israeli office of the chief scientist to support development of microrna oncology therapeutics aug   rosetta genomics announces launch of new website jun   novitas solutions issues final local coverage determination for rosetta cancer origin test jun   rosetta genomics to increase number of us sales territories may   rosetta genomics gets full settlement payment from sanra laboratories  appendix methodology about globaldata contact us disclaimer  rosetta genomics ltd key facts rosetta genomics ltd key pipeline products by equipment type rosetta genomics ltd key pipeline products by therapy area rosetta genomics ltd key pipeline products by development stage rosetta genomics ltd key facts rosetta genomics ltd major products and services rosetta genomics ltd number of pipeline products by equipment type rosetta genomics ltd pipeline products by equipment type rosetta genomics ltd number of pipeline products by development stage rosetta genomics ltd pipeline products by development stage rosetta genomics ltd number of pipeline products by therapy area rosetta genomics ltd pipeline products by therapy area rosetta genomics ltd number of pipeline products by milestone summary rosetta genomics ltd pipeline products by milestone summary body fluidsbased diagnostic test  cancer  product status body fluidsbased diagnostic test  cancer  product description body fluidsbased diagnostic test  cancer  patent details diagnostic test  melanoma  product status diagnostic test  melanoma  product description microrna test  congestive heart failure  product status microrna test  congestive heart failure  product description microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  congestive heart failure  patent details microrna test  gastric cancer recurrence  product status microrna test  gastric cancer recurrence  product description microrna test  gastric cancer recurrence  product milestone microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  gastric cancer recurrence  patent details microrna test  neurodegenerative disease  product status microrna test  neurodegenerative disease  product description microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  neurodegenerative disease  patent details microrna test  ovarian cancer  product status microrna test  ovarian cancer  product description microrna test  ovarian cancer  product milestone microrna test  ovarian cancer  patent details mirscreen test  colon cancer  product description mirscreen test  colon cancer  product milestone mirview test  bladder cancer  product status mirview test  bladder cancer  product description rosetta genomics ltd key employees rosetta genomics ltd pipeline products by equipment type rosetta genomics ltd pipeline products by development stage rosetta genomics ltd pipeline products by therapy area rosetta genomics ltd pipeline products by milestone summary  related reports global ultrasound gel warmer market professional survey report  this report studies ultrasound gel warmer in global market especially in north america china europe southeast asia japan and india with production revenue consumption import and export in these regions from  to  and forecast to this report focuses on top manufacturers in glob global surgical fixators market professional survey report  this report studies surgical fixators in global market especially in north america china europe southeast asia japan and india with production revenue consumption import and export in these regions from  to  and forecast to this report focuses on top manufacturers in global m global prosthetic foot market professional survey report  this report studies prosthetic foot in global market especially in north america china europe southeast asia japan and india with production revenue consumption import and export in these regions from  to  and forecast to this report focuses on top manufacturers in global mar global panoramic xray systems market professional survey report  this report studies panoramic xray systems in global market especially in north america china europe southeast asia japan and india with production revenue consumption import and export in these regions from  to  and forecast to this report focuses on top manufacturers in gl global ophthalmic knife market professional survey report  this report studies ophthalmic knife in global market especially in north america china europe southeast asia japan and india with production revenue consumption import and export in these regions from  to  and forecast to this report focuses on top manufacturers in global ma related news wound dressing market to gain from newly developed advanced technologies smart device that reads for visually impaired people view sample pdf purchase this market research report single license   multiple license   buy now download report pdf save page send an enquiry check discount request quote enquiry before buy popular reports global internal neuromodulation market size status and forecast  this report studies the global internal neuromodulation market analyzes and researches the internal neuromodulation development status and forecast in united states eu japan china india and southeast asia this report focuses on the top players in global market like cerbomed gmbh cyberonics in global tracheostomy market by manufacturers regions type and application forecast to  tracheotomy is a surgical procedure which consists of making an incision on the anterior aspect of the neck and opening a direct airway through an incision in the trachea windpipe the resulting stoma hole or tracheostomy can serve independently as an airway or as a site for a tracheostomy tub global atomic force microscope market by manufacturers countries type and application forecast to  atomicforce microscopy afm or scanningforce microscopy sfm is a veryhighresolution type of scanning probe microscopy spm with demonstrated resolution on the order of fractions of a nanometer more than  times better than the optical diffraction limit scope of the report this repor global neurology emr software market professional survey report  notes production means the output of neurology emr software revenue means the sales value of neurology emr software this report studies neurology emr software in global market especially in north america china europe southeast asia japan and india with production revenue consumption imp global elastic therapeutic zincpaste bandages market research report  this report studies the elastic therapeutic zincpaste bandages market status and outlook of global and major regions from angles of manufacturers regions product types and end industries this report analyzes the top manufacturers in global and major regions and splits the elastic therapeuti security check required facebookjoin or log into facebook   email or phonepasswordforgot accountlog indo you want to join facebooksign upsign upsecurity checkplease enter the text belowcant read the text abovetry another text or an audio captchatext in the boxwhats thissecurity checkthis is a standard security test that we use to prevent spammers from creating fake accounts and spamming userssubmitenglish usespañolfrançais franceالعربيةportuguês brasilitaliano한국어deutschहिन्दी語messengerfacebook litepeopleplacesgameslocationscelebritiesmarketplacegroupsrecipesmomentsinstagramaboutcreate adcreate pagedeveloperscareersprivacycookiesad choicestermssettingsactivity log facebook   rosetta genomics ltd rosg medical equipment deals and alliances profile report updated  prices from usd  — bioportfoliocom bioportfolio biotech healthcare and medical resources advertisement topics all topics biotechnology biotech business biotech products cancer cardiovascular dermatology drug discovery endocrinology gastroenterology immunology infectious diseases mental health neurology obstetrics orthopedics public health respiratory rheumatology urology  track topics on twitter track topics that are important to you printed from bioportfoliocom rosetta genomics ltd rosg medical equipment deals and alliances profile report updated  prices from usd   edt  jul   bioportfolio report blog summaryrosetta genomics ltd rgl is a developer of next generation diagnostic tests for personalized medicine the company provides testing services such as cancer origin nextgen thyroid lung prostate bladder breast kidney and specialty tests it also develops tests for thyroid neoplasia oncology kidney rejection alzheimers disease therapeutics and cmv the company offers rosettagx platform on the cutting edge of molecular science and genomic testing technologies with tests it operates in australia new zealand israel singapore canada greece india saudi arabia qatar the uae israel and turkey rgl is headquartered in rehovot israelrosetta genomics ltd rosg medical equipment deals and alliances profile provides you comprehensive data and trend analysis of the companys mergers and acquisitions mas partnerships and financings the report provides detailed information on mergers and acquisitions equitydebt offerings private equity venture financing and partnership transactions recorded by the company over a five year period the report offers detailed comparative data on the number of deals and their value categorized into deal types subsector and regionsglobaldata derived the data presented in this report from proprietary inhouse medical etrack deals database and primary and secondary researchscope financial deals analysis of the companys financial deals including mergers and acquisitions equitydebt offerings private equity venture financing and partnerships deals by year chart and table displaying information encompassing the number of deals and value reported by the company by year for a five year period deals by type chart and table depicting information including the number of deals and value reported by the company by type such as mergers and acquisitions equitydebt offering etc deals by region chart and table presenting information on the number of deals and value reported by the company by region which includes north america europe asia pacific the middle east and africa and south and central america deals by subsector chart and table showing information on the number of deals and value reported by the company by subsector major deals information on the companys major financial deals each such deal has a brief summary deal type deal rationale and deal financials and target companys major public companies key financial metrics and ratios business description a brief description of the companys operations key employees a list of the key executives of the company important locations and subsidiaries a list and contact details of key centers of operation and subsidiaries of the company key competitors a list of the key competitors of the company key recent developments a brief on recent news about the companyreasons to buyget detailed information on the companys financial deals that enable you to understand the companys expansiondivestiture and fund requirements the profile enables you to analyze the companys financial deals by region by year by business segments and by type for a five year periodunderstand the companys business segments expansion  divestiture strategy the profile presents deals from the companys core business segments perspective to help you understand its corporate strategyaccess elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company detailed information on major recent deals includes a summary of each deal deal type deal rationale deal financials and target companys key financial metrics and ratiosequip yourself with detailed information about the companys operations to identify potential customers and suppliers the profile analyzes the companys business structure locations and subsidiaries key executives and key competitorsstay uptodate on the major developments affecting the company recent developments concerning the company presented in the profile help you track important eventsgain key insights into the company for academic or business research key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needsnote some sections may be missing if data is unavailable for the company related biotechnology pharmaceutical and healthcare news rosetta genomics ltd rosetta genomics expands international access for rosettagx reveal through agreement with cytolog laboratories in brazil rosetta genomicss rosg ceo ken berlin on q  results  earnings call transcript rosetta genomics ltd rosg pharmaceuticals healthcare deals and alliances profile updated  prices from usd  rosetta genomics ltd rosg pharmaceuticals healthcare deals and alliances profile updated  prices from usd  rosetta genomics ltd rosetta genomics announces favorable results from two pilot studies comparing rosettagx reveal and the afirma gec assay for the classification of indeterminate thyroid nodules original article rosetta genomics ltd rosg medical equipment deals and alliances profile report updated  prices from usd  next article more from bioportfolio on rosetta genomics ltd rosg medical equipment deals and alliances profile report updated  prices from usd  related companies related events related clinical trials related pubmed entries related medications quick linksadvanced search  login  subscribe  rss quick search advertisement   relevant topics cancer disease cancer is not just one disease but many diseases there are more than  different types of cancer most cancers are named for the organ or type of cell in which they start  for example cancer that begins in the colon is called colon cancer cancer th thyroid disorders the thyroid is a butterflyshaped gland in the neck just above thecollarbone and is an endocrine gland that make hormones these thyroid hormones control the rate of many activities in the body including how fast the body burns calories and how fast th pulmonary pulmonary relating to or associated with the lungs eg asthma chronic bronchitis emphysema copd cystic fibrosis influenza  lung cancer pneumonia pulmonary arterial hypertension sleep disorders etc follow and track lung cancer news  news quicklinks search biotech medical and healthcare news popular biotech medical and healthcare news biotech news by article type biotech news by location bioportfolio bloggers publishing your news on bioportfolio recent visitor news searches bioportfolio limited about us contact us social media twitter  accounts twitter google linkedin publish content publish publish your press release advertise agreements agreements medical disclaimer privacy tools mybioportfolio rss help faqs sitemaps xml sitemap this site complies with the honcode standard for trustworthy health information verify here the information provided by bioportfoliocom is not a substitute for professional medical advice diagnosis or treatment the bioportfolio site is sponsored bioportfolio limited with offices at stafford house  prince of wales road dorchester dt pw england if you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “fair use” and legitimately infringes on your or your clients copyright we may be contacted concerning copyright matters at prioritybioportfoliocom all rights reserved all other trademarks recognized copyright   bioportfolio limited site developed by alacrify ltd rosetta genomics usa  rosettagx reveal™ to be highlighted in oral presentation at the rd world congress on thyroid cancer  traders log in email password remember forgot password  become a member for free sign up sign up new membersign up for free new customerdiscover our portfolios united states united kingdom france deutschland schweiz de suisse fr settings dynamic quotes  offon markets equities north americaeuropeasiaoceaniamiddle east» more equities indexes dow jonessp nasdaq tsx compftse » more indexes currency  forex eur  usdgbp  usdusd  jpyusd  cadaud  usd» more currencies commodities goldcrude oil wticrude oil brentsilverplatinum» more commodities news latest news companiesmarketseconomycurrency  forexcommoditiesinterest ratesbusiness leadersfinancial calendareconomic calendar listed company analyst recorumorsiposcapital markets transactionsnew contractsprofits warningsappointmentspress releaseseventscorporate actions sector news energybasic materialsindustrialsconsumer cyclicalconsumer noncyclicalfinancialshealthcaretechnologytelecommunications servicesutilities analysis all analysiscommentariesindex analysisstock trading strategiescommodity analysisforex analysis stock picks all stock picks portfolios my portfolio virtual portfolios traders portfolios european portfoliousa portfolioasian portfolio screeners market screener homefundamental analyse top investor ratingtop trading ratingtop consensusgrowth stocksyield stockslow valuations technical analysis oversold stocksoverbought stocksclose to resistancesclose to supportsaccumulation phasemost volatile stocks watchlists my watchlists watchlists top lists yield stocksgrowth stocksundervalued stocks top  flop top news most read newshot news top fundamentals top capitalizationtop yieldtop pertop consensustop fundamentals top technicals top rsiunusual volumestop gapstop stim top movers top usatop canadatop uktop germanytop europetop asia tools market screenerdynamic chartfinancial calendareconomic calendarsector researchcurrency converter our services premium accessdiscover our services traders homepage    equities    nasdaq    rosetta genomics ltd usa    rosg   il rosetta genomics ltd usa rosg add to my list    mes dernières consultmost popular manage my lists  delayed     pm  usd     rosetta genomic  rosettagx reveal™ to be highlighted in oral   rosetta genomic  expands patent portfolio in canada united states   rosetta genomic  announces favorable results from two pilot studies summaryquoteschartsnewscalendarcompanyfinancialsconsensusrevisions news summarymost relevantall newssector newstweets rosetta genomics usa  rosettagx reveal™ to be highlighted in oral presentation at the rd world congress on thyroid cancer    pm cest send by mail  last name  name  from  to  you can enter multiple email addresses separated by commas message  required fields rosettagx reveal™ to be highlighted in oral presentation at the rd world congress on thyroid cancer survey of clinical use demonstrates potential for significant reduction in unnecessary surgeries associated with indeterminate thyroid nodules philadelphia and rehovot israel july    rosetta genomics ltd nasdaq rosg a genomic diagnostics company that improves treatment decisions by providing timely and accurate diagnostic information to physicians announces that data highlighting the integration of the rosettagx reveal™ into clinical practice will be presented in an oral presentation at the rd world congress on thyroid cancer taking place july   at the westin boston waterfront in boston ma the rosettagx reveal microrna classifier is a first ofitskind assay offering testing from a routinely prepared cytology slide that analyzes the exact cells used to make the original indeterminate diagnosis the following oral presentation related to rosettagx reveal will be delivered during the congress presentation title incorporating the rosettagx reveal™ assay into clinical practice can significantly reduce the number of unnecessary surgeries associated with indeterminate thyroid nodules itns presenter nicole massoll md lab and medical director of rosetta genomics date sunday july   time  am eastern time location marina ballroom about rosetta genomics rosetta is pioneering the field of molecular diagnostics by offering rapid and accurate diagnostic information that enables physicians to make more timely and informed treatment decisions to improve patient care rosetta has developed a portfolio of unique diagnostic solutions for oncologists urologists endocrinologists cytopathologists and other specialists to help them deliver better care to their patients rosettagx reveal™ a thyroid microrna classifier for the diagnosis of cancer in thyroid nodules as well as the full rosettagx™ portfolio of cancer testing services are commercially available through the companys philadelphia pa and lake forest cabased capaccredited cliacertified labs forwardlooking statement disclaimer various statements in this release concerning rosettas future expectations plans and prospects including statements containing the words expect believe will may should project estimate anticipated scheduled and like expressions and the negative thereof constitute forwardlooking statements for the purposes of the safe harbor provisions under the private securities litigation reform act of  actual results may differ materially from those indicated by these forwardlooking statements as a result of various risks and uncertainties including but are not limited to the following we will require substantial additional funds to continue our operations and if additional funds are not available we may need to significantly scale back or cease our operations we have a history of losses and may never be profitable if we are unable to expand sales of our diagnostic tests in the united states it would have a material adverse effect on our business and financial condition if we are unable to find profitable strategic alternatives for our personalizedx diagnostic testing and services business it would have a material adverse effect on our business and financial condition the intensely competitive biotechnology market could diminish demand for our tests and products the market may not be receptive to any diagnostic tests or therapeutic products using our microrna technology we currently have limited sales marketing or distribution experience and may in the future depend significantly on third parties to commercialize micrornabased diagnostic tests or therapeutic products we may develop we are largely dependent upon our distributors for the success of commercialization of our current diagnostic tests health insurers and other thirdparty payors may decide not to cover our diagnostic products or may provide inadequate reimbursement which could jeopardize our commercial prospects because of medicare billing rules we may not receive reimbursement for all tests provided to medicare patients if we fail to comply with our obligations under any licenses or related agreements we could lose license rights that may be necessary for developing micrornabased diagnostics and therapeutics if we fail to comply with the complex federal state local and foreign laws and regulations that apply to our business we could suffer severe consequences that could materially and adversely affect our operating results and financial condition we contract with a single manufacturer for the purchase of microarray chips for certain tests and the failure of this manufacturer to supply sufficient quantities on a timely basis could have a material adverse effect on our business and other risk factors discussed under the heading risk factors in rosettas most recently filed annual report on form f as filed with the sec in addition any forwardlooking statements represent rosettas views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date rosetta does not assume any obligation to update any forwardlooking statements unless required by law various statements in this release concerning rosettas future expectations plans and prospects constitute forwardlooking statements for the purposes of the safe harbor provisions under the private securities litigation reform act of  actual results may differ materially from those indicated by these forwardlooking statements as a result of various important factors including those risks more fully discussed in the risk factors section of rosettas most recently filed annual report on form f as filed with the sec in addition any forward looking statements represent rosettas views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date rosetta does not assume any obligation to update any forwardlooking statements unless required by law rosetta genomics contact rosetta genomics investor contact ken berlin president  ceo lha   anne marie fields investorsrosettagxcom   afieldslhaicom    rosetta genomics ltd published this content on  july  and is solely responsible for the information contained herein distributed by public unedited and unaltered on  july   utc original documenthttprosettagxcomfilespressreleaseseecafcefpdf public permalinkhttpwwwpublicnowcomviewedddfcbbbeacb  latest news on rosetta genomics ltd usa  rosetta genomics usa  rosettagx reveal™ to be highlighted in oral present  rosetta genomics ltd usa  rosettagx revealtm to be highlighted in oral pre  rosetta genomics usa  expands patent portfolio in canada united states and chi  rosetta genomics ltd usa  rosetta genomics expands patent portfolio in canad  rosetta genomics ltd usa  rosetta genomics granted european patent allowance  rosetta genomics ltd usa  rosetta genomics enters collaboration to develop a  rosetta genomics ltd usa  rosetta genomics focusing efforts on improving cas  rosetta genomics usa  announces favorable results from two pilot studies compar  rosetta genomics ltd usa  rosetta genomics announces favorable results from   rosetta genomics usa  expands international access for rosettagx revealtm throu more news news from seekingalpha  midday gainers  losers  rosetta genomics readies equity offering shares down   healthcare  top  gainers  losers   am  week ahead  fireworks on independence day and maybe at the g and qatar too  week ahead  wall streets keys financials  more financials chart rosetta genomics ltd usa duration  auto  months  months  months  months  year  years  years  years max period  day week fullscreen chart income statement evolution please enable javascript in your browsers settings to use dynamic charts more financials consensus sell buy mean consensus outperform number of analysts  average target price   spread  average target   consensus details eps revisions please enable javascript in your browsers settings to use dynamic charts more estimates revisions managers nametitlekenneth a berlin president  chief executive officer brian a markison chairman ron kalfus chief financial officer eti meiri vice presidentresearch  development joshua rosensweig independent director more about the company sector and competitors st jancapitalization m rosetta genomics ltd usa incyte corporation  quintiles ims holdings inc  lonza group  celltrion inc  alkermes plc  more results traderscom marketsnewsanalysisstock picksportfoliosscreenerswatchliststop  floptoolsour servicesabout surperformance sascontact usadvertiselegal informationsabout usstay connected facebooktwitterpartners börse aktien kurse und nachrichtenbest tweets copyright   surperformance all rights reserved slave creative commons — attributionsharealike  unported — cc bysa  skip to content menu help us build a vibrant collaborative global commons donate now creative commons creative commons license deed attributionsharealike  unported cc bysa  this is a humanreadable summary of and not a substitute for the license disclaimer you are free to share — copy and redistribute the material in any medium or format adapt — remix transform and build upon the material for any purpose even commercially the licensor cannot revoke these freedoms as long as you follow the license terms under the following terms attribution — you must give appropriate credit provide a link to the license and indicate if changes were made you may do so in any reasonable manner but not in any way that suggests the licensor endorses you or your use attribute this work sharealike — if you remix transform or build upon the material you must distribute your contributions under the same license as the original no additional restrictions — you may not apply legal terms or technological measures that legally restrict others from doing anything the license permits notices you do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation no warranties are given the license may not give you all of the permissions necessary for your intended use for example other rights such as publicity privacy or moral rights may limit how you use the material learn more about cc licensing or use the license for your own material this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work make a donation this page is available in the following languages castellano castellano españa català dansk deutsch english esperanto français galego hrvatski indonesia italiano latviski lietuvių melayu nederlands norsk polski português português br română slovenščina suomeksi svenska türkçe íslenska česky ελληνικά беларуская русский українська العربية پارسی  語   한국어 this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work when you share everyone wins contribute today to creative commons     disclaimer this deed highlights only some of the key features and terms of the actual license it is not a license and has no legal value you should carefully review all of the terms and conditions of the actual license before using the licensed material creative commons is not a law firm and does not provide legal services distributing displaying or linking to this deed or the license that it summarizes does not create a lawyerclient or any other relationship what does attribute this work mean the page you came from contained embedded licensing metadata including how the creator wishes to be attributed for reuse you can use the html here to cite the work doing so will also include metadata on your page so that others can find the original work as well the applicable mediation rules will be designated in the copyright notice published with the work or if none then in the request for mediation unless otherwise designated in a copyright notice attached to the work the uncitral arbitration rules apply to any arbitration more info if supplied you must provide the name of the creator and attribution parties a copyright notice a license notice a disclaimer notice and a link to the material cc licenses prior to version  also require you to provide the title of the material if supplied and may have other slight differences more info in  you must indicate if you modified the material and retain an indication of previous modifications in  and earlier license versions the indication of changes is only required if you create a derivative marking guide more info you may also use a license listed as compatible at httpscreativecommonsorgcompatiblelicenses more info a commercial use is one primarily intended for commercial advantage or monetary compensation more info merely changing the format never creates a derivative more info the license prohibits application of effective technological measures defined with reference to article  of the wipo copyright treaty more info the rights of users under exceptions and limitations such as fair use and fair dealing are not affected by the cc licenses more info you may need to get additional permissions before using the material as you intend more info genomic testing  rosetta gx™ by rosetta genomics® get in touch rosettagx™ testing services provide physicians a direct path for diagnosing cancer and optimizing patient treatment outcomes view clinical validation for rosettagx reveal  thyroid classifier read more view analytical validation for rosettagx reveal  thyroid classifier read more learn about our thyroid test  rosettagx reveal watch now view clinical validation for rosettagx reveal  thyroid classifier read more view analytical validation for rosettagx reveal  thyroid classifier read more learn about our thyroid test  rosettagx reveal watch now rosettagx provides physicians a direct path for diagnosing cancer and optimizing patient treatment outcomes your cancer roadmap is here specialized diagnostic prognosticand predictive testing genomic answers that revealthe optimal treatment plan learn more micrornabased assay for diagnosing tumor tissue origin oncologist   flexible ordering options order now view our specialty tests view for our investors press releases  presentations r  companies market research reports  r  companies industry analysis  marketresearchcom about us solutions resources ebookswhite papers slideshares videos blog contact us register log in my account logout browse research my cart menu   close   x browse about us solutions resources contact us log out register log in market research » company reports r  companies market research reports  industry analysis company reports will allow you to view a summary of an organisations key facts and figures plus an overview of the key markets in which they operate company reports will give a company history and an analysis of their current competitor situation their strategic position in the market will also be analysed with a swot analysis and subsequent sections of the report will go on to list the key employees within the organisation plus a biography on those employees where appropriate other areas covered include revenue information by sector and geography plus the organisations physical location plus any subsidiaries in the reports section for companies beginning with the letter r you may find information on the following businesses reckitt  colman reed elsevier reuters group  rio tinto roche rohm  haas rollsroyce royal and sun alliance insurance royal bank of canada royal dutchshell group show more show less filter your search filter your search europe  asia  global  north america  south america  africa  oceania  middle east  caribbean  research assistance us  intl  join alert me now receive biweekly email alerts on new research sign up find out more on our blog r  companies industry research  market reports sort by title az title za price lowtohigh price hightolow date date older first refine your search close window refine your search title publisher keyword priceusd to date any date last month last  months last  months last year last  years region all regions africa    algeria    angola    benin    botswana    burkina faso    burundi    cameroon    cape verde    central african republic    chad    comoros    the congo    the congo    cote divoire    djibouti    egypt    equatorial guinea    eritrea    ethiopia    gabon    the gambia    ghana    guinea    guineabissau    kenya    lesotho    liberia    libya    madagascar    malawi    mali    mauritania    mauritius    mayotte    morocco    mozambique    namibia    niger    nigeria    reunion    rwanda    sao tome and principe    senegal    seychelles    sierra leone    somalia    south africa    south sudan    sudan    swaziland    tanzania    togo    tunisia    uganda    western sahara    zambia    zimbabwe asia    afghanistan    armenia    azerbaijan    bangladesh    bhutan    brunei    cambodia    china    cocos keeling islands    east timor    georgia    hong kong    india    indonesia    japan    kazakhstan    kyrgyzstan    laos    macau    malaysia    maldives    mongolia    myanmar    nepal    north korea    pakistan    papua new guinea    philippines    russia    singapore    south korea    sri lanka    taiwan    tajikistan    thailand    turkey    turkmenistan    uzbekistan    vietnam caribbean    anguilla    antigua and barbuda    aruba    the bahamas    barbados    british virgin islands    cayman islands    cuba    curacao    dominica    dominican republic    grenada    guadeloupe    haiti    jamaica    martinique    montserrat    netherlands antilles    puerto rico    saint kitts and nevis    saint lucia    saint vincent and the grenadines    sint maarten saint maarten    trinidad and tobago    turks and caicos islands    virgin islands central america    belize    costa rica    el salvador    guatemala    honduras    nicaragua    panama europe    albania    andorra    austria    belarus    belgium    bosnia and herzegovina    bulgaria    croatia    czech republic    denmark    estonia    faroe islands    finland    france    germany    gibraltar    greece    guernsey    hungary    iceland    ireland    isle of man    italy    jersey    kosovo    latvia    liechtenstein    lithuania    luxembourg    macedonia    malta    moldova    monaco    netherlands    norway    poland    portugal    romania    san marino    scotland    serbia and montenegro    slovakia    slovenia    spain    sweden    switzerland    ukraine    united kingdom global middle east    bahrain    cyprus    gaza strip    iran    iraq    israel    jordan    kuwait    lebanon    oman    palestinian territories    qatar    saudi arabia    syria    united arab emirates    yemen north america    bermuda    canada    greenland    mexico    united states oceania    american samoa    australia    cook islands    fiji    french polynesia    guam    kiribati    marshall islands    micronesia federated states of    nauru    new caledonia    new zealand    niue    norfolk island    northern mariana islands    palau    samoa    solomon islands    tonga    tuvalu    vanuatu south america    argentina    bolivia    brazil    chile    colombia    ecuador    falkland islands    french guiana    guyana    paraguay    peru    suriname    uruguay    venezuela search royal frieslandcampina nv in packaged food world jul    usd  in asia pacific and the middle east and africa its baby food sales are largely derived from emerging markets in asia pacific notably china the group recently expanded into new markets in africa and also  read more red river valley mutual insurance company  company profile and swot analysis jun    usd  major products and services swot analysis business description company history financial analysis recent developments as well as key employees summary this report is a crucial resource for industry executives and anyone looking to access key  read more reliance insurance limited reliancins  company profile and swot analysis jun    usd  and services swot analysis business description company history financial analysis key employees company locations and subsidiaries as well as employee biographies summary this report is a crucial resource for industry executives and anyone looking to  read more rotkäppchenmumm sektkellereien gmbh in alcoholic drinks germany jun    usd  the company to compensate for the declining consumption of sparkling wine in germany which greatly affects its core business because the company is the leading player in sparkling wine in germany euromonitor international local company  read more radeberger gruppe kg in alcoholic drinks germany jun    usd  its national and regional brands both through the organic growth of its brands and sites and through acquisition euromonitor international local company profiles are a concise set of briefings detailing the strategic direction taken by  read more rad source technologies inc  strategic swot analysis review jun    usd  company’s key employees key competitors and major products and services this uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners customers and competitors better  read more regeneron pharmaceuticals inc regnnas analytics extensive financial metrics and benchmarks against averages and top companies within its industry jun    usd  its top competitors and compared to the average for all companies within its primary industry  benchmarking study for regeneron pharmaceuticals inc  includes growth forecast for its primary industry to the year  the  read more reliance retail ltd in toys and games india jun    usd  stores across  cities and plans to double its store count by  besides high streets in major cities in india the company is also targeting smaller tier  cities under different store formats such  read more revlon inc in beauty and personal care world jun    usd  innovation pipeline has been to the detriment of all its colour cosmetics brands greater focus is also imperative in other highopportunity zones such as fragrances in latin america revlon is challenged in both developed and  read more redhead family corp in toys and games ukraine jun    usd  redhead family corp plans to widen its chain and more importantly make it more convenient for children children should have the possibility to try toys before purchasing moreover the company plans to provide more entertainment  read more ricard sa in alcoholic drinks france jun    usd  anticipating shipments over  in addition as france had already dropped to fourth position just behind india in  the activities of its pernod and ricard subsidiaries had to become more tactical in its core  read more royal canin india pvt ltd in pet care india jun    usd  the country euromonitor international local company profiles are a concise set of briefings detailing the strategic direction taken by a company discover key contact details the company background and their competitive positioning through this collection  read more respirerx pharmaceuticals inc rspi  financial and strategic swot analysis review jun    usd  to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats the profile helps you formulate strategies that augment your business by enabling you to  read more reshet cafe cafe ltd in consumer foodservice israel jun    usd  a mall version of fresh kitchen called fresh express the company plans to grow by franchising its brands and expanding its existing restaurants while seeking new brands to invest in euromonitor international local company profiles  read more reckitt benckiser sweden in home care sweden jun    usd  from home care and possibly the spinoff or divestment of its home care operations euromonitor international local company profiles are a concise set of briefings detailing the strategic direction taken by a company discover key  read more royal dsm nv dsm  financial and strategic swot analysis review may    usd  to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats the profile helps you formulate strategies that augment your business by enabling you to  read more reynolds american inc rai  financial and strategic swot analysis review may    usd  to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats the profile helps you formulate strategies that augment your business by enabling you to  read more resolute mining limited rsg  company profile and swot analysis may    usd  the profile contains a company overview key facts major products and services swot analysis business description company history financial analysis mergers  acquisitions recent developments key employees company locations and subsidiaries employee biographies as well  read more rockwell medical inc rmti  financial and strategic swot analysis review may    usd  to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats the profile helps you formulate strategies that augment your business by enabling you to  read more restaurant brands international inc in consumer foodservice canada may    usd  the company is also moving into retail in  its tim hortons brand entered retail with a new bottled iced capp in addition tim hortons benefited from heavy investment in new menu items  saw  read more rolf c hagen inc in pet care canada may    usd  its distribution network while also working to improve the quality of its established product ranges in particular it aims to focus on the development of new pet products including pet healthcare items and pet accessories  read more randox laboratories ltd  product pipeline analysis  update may    usd  others it offers diagnostic prognostic and predictive solutions for cardiovascular disease infectious disease and cancer randox also provides testing services its products find application in various areas including hospital laboratories clinical research and molecular laboratories  read more reckitt benckiser group plc in home care world may    usd  of the acquisition for the operations of the world’s third largest home care player considering which home care brands are compatible with its evolving corporate identity and which are marginalised by its strategic development it  read more renault sa rno  financial and strategic swot analysis review may    usd  you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats the profile helps you formulate strategies that augment your business by enabling you to understand  read more retail food group ltd in consumer foodservice australia may    usd  also announced its plan to continue diversifying its revenue streams through acquisitions and overseas expansion euromonitor international local company profiles are a concise set of briefings detailing the strategic direction taken by a company discover  read more  prev           next  start new browse consumer goods food  beverage heavy industry life sciences marketing  market research public sector service industries technology  media company reports reports by country view all market areas view all publishers kidney test  rosettagx™ by rosetta genomics® get in touch directory of services order tests kidney cancer origin nextgen thyroid lung prostate bladder breast kidney subtypes of renal tumors in kidney cancer patients have different genetic backgrounds prognoses and responses to surgical and medical treatment and their differential diagnosis is a frequent challenge mikidney provides that differential diagnosis with fast standardized and subjective classification this molecular diagnostic test serves clinicians by differentiating the  main histological types of primary kidney tumors benign oncocytoma and the  most common subtypes of renal cell carcinomas clear cell papillary and chromophobe accurately classifies the four most common kidney tumors benign oncocytoma clear cell papillary and chromophobe provides definitive results on kidney biopsies to avoid unnecessary surgeries overall accuracy of  rapid turnaround time of  days evidence evidence read studies about mikidney™ spector y fridman e rosenwald s et al development and validation of a micrornabased diagnostic assay for classification of renal cell carcinomas mol oncol  fridman e dotan z barshack i et al accurate molecular classification of renal tumors using microrna expression j mol diagn  references spector y fridman e rosenwald s et al development and validation of a micrornabased diagnostic assay for classification of renal cell carcinomas mol oncol  rosg conversations  rosetta genomics ltd  ordinar  yahoo financehomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoreyahoosearchsearchus markets close in  hrs  minssp  dow  rosetta genomics ltd rosgnasdaqcm  nasdaqcm real time price currency in usdadd to watchlist as of am edt market openpeople also watchrxiipsticlsncyccopxasummaryconversationsstatisticsprofilefinancialsoptionsholdershistorical dataanalysts reactions on rosg conversationsign in to post a messagetop reactionsbbluegedy for ascary scary crash crashbelow  be veryvery af money run run to the exit exit door get ouout beterbesafe than sorryreplynnickhas anyone tried actually suing this company before just curious im in on small shares but jeez i have never ever seen this thing going up where are the lawsuitsreplyreplies llittleguywhen if ever has a management action resulted in a higher stock price it seems to me that any rise in share price is an invitation by management to bring it back downreplyreplies jjakewhen the pumpers came in last couple of weeks i knew that this was going to take a chtz shorts love this stock ken berlin will be looking over his shoulder for the rest of his life fbi etc all for greedreplyreplies jjustinkenny lie on may stsince announcing our strategic focus on rosettagx reveal™ reveal and the exploration of alternatives for our personalizedx business at the start of this month we have received inquiries from multiple parties expressing interest in acquiring our personalizedx business said kenneth a berlin president and chief executive officer of rosetta genomics in parallel the current market conditions for selling equity are not favorable to microcap companies and we believe the terms proposed to us by potential investors are not in the best interest of our shareholders as such we are suspending plans to raise capital under the form f registration statement until further notice and instead will continue to explore other means to improve our cash position the potential sale of our personalizedx business would have the benefit of bringing in nondilutive cash as well as reducing our cash burn rate by approximately  we also are pursuing opportunities to monetize certain ip assets which represent another potential source of nondilutive cash and are exploring several other avenues for raising capitalmorereplymmichaelhuge dillution back onmaybe gets done under  with warrants like m new sharescan you say reverse splitreplyreplies jjaketold u soreplyssamrosetta genomics files for m offering of class a class b units warrantsreplyreplies llittleguy of market cap last i read kens annual salary is k thats over  of market cap imagine if any other ceo were paid that much  company with stinking leadershipreplyreplies nnicki understand the ceo is in israel trying to avoid sec charges and lawsuits against him and his cronies theres got to be some way to get the guy since its listed on the nasdaq america can still go after foreign nationals i am assuming he is american or is he isrealireplyreplies jjasonwhat a liar what happened to multiple parties interested in buying personalizeddx not two months ago glad i got out with  profits but this guy is totally full of itreplyjjasontrash took profits kenny totally lied too bad i believe in reveal but share count is increasing exponentially nowreplyvvjpersonalizedx business will not even fetch kens  months worth of salaryreplyaanonymousktov  mcap  mil cash  mil  ultra low float  nda submission for potential blockbuster this quarter   bagger one of the biggest biotech opportunity ever  thank me later guyskitov pharma ktovmarket cap  mcash  mprice shares out  millionkitov pharmaceuticals initiates nda filing for kit as a treatment for osteoarthritis and hypertensionhttpsbaystreetcaarticlesresearchreportslifescikitovpdfkitov expects to submit an nda for kit in the third quarter kitov announced that it began the process of compiling the documents necessary to file an nda for its lead asset kit as a treatment for patients who experience both osteoarthritis and hypertension the company hired parexel international corporation a clinical research organization to digitalize and formally submit its nda application kitov expects the filing to occur during the third quarter of  with a potential fda approval during the second quarter of kit is a combination drug that treats osteoarthritis pain and hypertension simultaneouslyprimary efficacy endpoint achieved lead drug candidate kit achieved its primary efficacy endpoint in a pivotal phase iii trialmarketing potential pipeline candidates address large multibillion dollar marketsproductskitov’s current pipeline products kit and kit are combination drugs that treat oa pain and htn simultaneously in december  kit successfully achieved the primary efficacy endpoint for its phase iii clinical trial in august  the united states patent office issued a patent covering kitmarketof the  million americans with oa  also suffer from htn which is also a common side effect of standalone oa drugs with no single medication currently treating both conditions kit and kit are targeting this multibillion dollar marketmorereplymmywhat a cheat so what hold againreplyjjustinvreveal is real im a recent investor to rosg with an average buyin price of around  and now have substantial ownership of rosg both my father and my sister had thyroid surgery because their lab tests came back as indeterminate fortunately both cases were benign  the point being that reveal could likely have saved s to the insurance companythis product alone is worth a  million valuation now that its approved and marketed not to mention all the other ip rosg at these price levels is a crazy bargain and someone has figured it out and is accumulating last chance to buy at these levels in my opinionmorereplyreplies jjustinkenny selling shares before erreplymmichaeldidnt liejust spent to much cash cant sell personal dx giving away  percent if the company for  to  million bucks will get done under  dollarreplyreplies vvjmichael we had  million in january we should run out of cash by aug   assuming same burn rate like last year hopefullly with some reduction in staff and reveal revenue the fund could last till sept if personalized dx is sold it would buy another  weeksso mr berlin will have some good announcement in july and he will follow that up with atm we need to get out before atmmorereplyreplies jjasoni predict we will hear about the sale of personalizeddx in july or august and it will bring in a lot more money than many of you are expecting  giving the company some very solid nondilutive funding i believe there are quite a few entities out there bidding for personalizeddexreplyshow moretrump’s unwitting legacy could be universal health coverageyahoo financesolar eclipse  stay in the tualatin valleythe tualatin valleysponsoredsean hannity responds to claim he ran up a  tab at trumps hotel after flying in a yearold lobster from mainebusiness insideryahoo small businessdata disclaimerhelpsuggestionsprivacyabout our adsterms updated